<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">96713</article-id>
<article-id pub-id-type="doi">10.7554/eLife.96713</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96713.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Computational and Systems Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9622-0184</contrib-id>
<name>
<surname>Roy</surname>
<given-names>Gitanjali</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Syed</surname>
<given-names>Rameesha</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lazaro</surname>
<given-names>Olivia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robertson</surname>
<given-names>Sylvia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3401-5334</contrib-id>
<name>
<surname>McCabe</surname>
<given-names>Sean D.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0907-464X</contrib-id>
<name>
<surname>Mawla</surname>
<given-names>Alex M.</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4628-2256</contrib-id>
<name>
<surname>Johnson</surname>
<given-names>Travis S.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8349-9470</contrib-id>
<name>
<surname>Kalwat</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Indiana Biosciences Research Institute</institution>, Indianapolis, IN, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine</institution>, Indianapolis, IN, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Department of Biostatistics and Health Data Science, Indiana University School of Medicine</institution>, Indianapolis, IN, <country>USA</country></aff>
<aff id="a4"><label>4</label><institution>Department of Neurobiology</institution>, Physiology and Behavior, <institution>College of Biological Sciences, University of California</institution>, Davis, Davis, CA</aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Sussel</surname>
<given-names>Lori</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Colorado Anschutz Medical Campus</institution>
</institution-wrap>
<city>Aurora</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Sussel</surname>
<given-names>Lori</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Colorado Anschutz Medical Campus</institution>
</institution-wrap>
<city>Aurora</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence: <email>mkalwat@indianabiosciences.org</email> and <email>johnstrs@iu.edu</email></corresp>
<fn fn-type="equal" id="n1"><label>†</label><p>Equal contributors.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-06-25">
<day>25</day>
<month>06</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP96713</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-02-28">
<day>28</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-01-23">
<day>23</day>
<month>01</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.01.18.576260"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Roy et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Roy et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-96713-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Diabetes affects &gt;10% of adults worldwide and is caused by impaired production or response to insulin, resulting in chronic hyperglycemia. Pancreatic islet β-cells are the sole source of endogenous insulin and our understanding of β-cell dysfunction and death in type 2 diabetes (T2D) is incomplete. Single-cell RNA-seq data supports heterogeneity as an important factor in β-cell function and survival. However, it is difficult to identify which β-cell phenotypes are critical for T2D etiology and progression. Our goal was to prioritize specific disease-related β-cell subpopulations to better understand T2D pathogenesis and identify relevant genes for targeted therapeutics. To address this, we applied a deep transfer learning tool, DEGAS, which maps disease associations onto single-cell RNA-seq data from bulk expression data. Independent runs of DEGAS using T2D or obesity status identified distinct β-cell subpopulations. A singular cluster of T2D-associated β-cells was identified; however, β-cells with high obese-DEGAS scores contained two subpopulations derived largely from either non-diabetic or T2D donors. The obesity-associated non-diabetic cells were enriched for translation and unfolded protein response genes compared to T2D cells. We selected DLK1 for validation by immunostaining in human pancreas sections from healthy and T2D donors. DLK1 was heterogeneously expressed among β-cells and appeared depleted from T2D islets. In conclusion, DEGAS has the potential to advance our holistic understanding of the β-cell transcriptomic phenotypes, including features that distinguish β-cells in obese non-diabetic or lean T2D states. Future work will expand this approach to additional human islet omics datasets to reveal the complex multicellular interactions driving T2D.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>β-cells</kwd>
<kwd>ER stress</kwd>
<kwd>unfolded protein response</kwd>
<kwd>heterogeneity</kwd>
<kwd>single-cell RNA-seq</kwd>
<kwd>machine learning</kwd>
<kwd>deep transfer learning</kwd>
<kwd>diabetes</kwd>
<kwd>computational biology</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="external-links">
<fn fn-type="dataset"><p>
<ext-link ext-link-type="uri" xlink:href="https://github.com/kalwatlab/Islet_DEGAS_v1">https://github.com/kalwatlab/Islet_DEGAS_v1</ext-link>
</p></fn>
<fn fn-type="dataset"><p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17632/3sdxv5tzbd.1">https://doi.org/10.17632/3sdxv5tzbd.1</ext-link>
</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Background</title>
<p>The advent of high-throughput single-cell RNA sequencing (scRNA-seq) has enabled the generation of an array of single-cell atlases from pancreatic islets. These findings have expanded our understanding of the major cell types of the pancreas along with how they are implicated in both type 1 diabetes (T1D) and type 2 diabetes (T2D). Notably, these studies have: 1) identified multiple reliable transcriptomic markers for endocrine and exocrine pancreatic cell types; 2) provided insight into novel subtypes of cells; and 3) generated large cellular atlases spurring innovation in the development of single cell methods and analysis. scRNA-seq analysis has enabled a more robust characterization of islet cell heterogeneity which may underlie diversity in diabetes risk and drug response <sup><xref ref-type="bibr" rid="c1">1</xref>–<xref ref-type="bibr" rid="c5">5</xref></sup>. In published comparisons between the islet single-cell transcriptomes of humans versus mice and pigs, differences were observed in the relative proportion of major cell types as well as in many cell type-specific genes <sup><xref ref-type="bibr" rid="c6">6</xref></sup>. These findings further support a focus on integrating human islet transcriptomic data to delineate disease processes and identify therapeutic targets and biomarkers.</p>
<p>As bulk RNA-seq and scRNA-seq human islet datasets have become increasingly available, so too has the need for new computational tools to integrate the transcriptomics and donor metadata. Some sets of islet scRNA-seq data have been combined and made searchable through web portals to browse datasets and compare cell types and marker genes <sup><xref ref-type="bibr" rid="c6">6</xref>–<xref ref-type="bibr" rid="c9">9</xref></sup>. To further utilize these types of integrated transcriptomic data and donor metadata, we previously developed DEGAS as a flexible deep transfer learning framework that can be used to overlay disease status, survival hazard, drug response, and other clinical information directly onto single cells. Machine learning tools like DEGAS have been primarily used in cancer datasets, but not in human pancreatic islets until now.</p>
<p>The reasons why some obese individuals succumb to T2D while other do not likely involves both genetic and environmental factors, but the factors that underlie this transition are incompletely understood<sup><xref ref-type="bibr" rid="c10">10</xref></sup>. Analyses of human genomics and islet transcriptomics indicate many β-cell genes have causal roles in T2D <sup><xref ref-type="bibr" rid="c11">11</xref>–<xref ref-type="bibr" rid="c15">15</xref></sup>. Subsets of β-cells which are more resilient or susceptible to failure under the secretory pressure of insulin resistance may be uncovered by combining transcriptomics with machine learning approaches like DEGAS. Here we have implemented DEGAS to predict T2D- and obesity-associated subclusters of human pancreatic islet β-cells using a combination of publicly available scRNA-seq and bulk RNA-seq human islet data and associated donor metadata. Through this analysis we sought to identify novel and established genes implicated in T2D and obesity, which were up- or down-regulated in subpopulations of β-cells identified by DEGAS, and to validate our findings at the protein level using immunohistochemistry of pancreas tissue from non-diabetic and T2D organ donors. Our current findings applying DEGAS to islet data have implications for β-cell heterogeneity in T2D and obesity. The abundance of T2D-related factors and functional β-cell genes in our analysis validates applying DEGAS to islet data to identify disease associated phenotypes and increase confidence in the novel candidates.</p>
</sec>
<sec id="s2">
<title>Data description</title>
<sec id="s2a">
<title>Human islet bulk transcriptomic dataset acquisition, processing, and analysis</title>
<p>In this study, human islet bulk RNA-seq raw count data (aligned to GRCh38) and donor metadata from Marselli, et al. GSE159984 was downloaded from the Gene Expression Omnibus <sup><xref ref-type="bibr" rid="c16">16</xref></sup> (<bold>Table S1</bold>). The rationale for using this dataset was its large sample size of both non-diabetic and T2D samples and the agreement of differentially-expressed genes between the GSE159984 dataset and a similarly large independent dataset<sup><xref ref-type="bibr" rid="c17">17</xref></sup>. All genes in the read count data were filtered based on the one-to-one identifier correspondences between gene symbol, Entrez gene identifier, and Ensembl identifier from the Matched Annotation from NCBI and EBI table (MANE GRCh38 v1.1) <sup><xref ref-type="bibr" rid="c18">18</xref></sup>.</p>
<p>Sample data were labeled and grouped by their RRID and disease status (ND, non-diabetes vs. T2D, type 2 diabetes). After filtering, the GSE159984 read count table contained 19,058 genes from N = 27 T2D samples and N = 58 non-diabetes samples (<bold><xref rid="fig1" ref-type="fig">Fig 1A</xref></bold>). Differential gene expression analysis between ND and T2D groups was performed using the edgeR likelihood ratio test and cutoffs were FDR ≤ 0.05 and |log<sub>2</sub> fold-change| ≥ 0.58. The processed and filtered read count table and edgeR results are provided in <bold>Table S2</bold> and the R script used for processing is available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/kalwatlab/Islet_DEGAS_v1">https://github.com/kalwatlab/Islet_DEGAS_v1</ext-link>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Data acquisition and workflow to train DEGAS using human pancreatic islet transcriptomic data for prediction of T2D-associated cells.</title><p><bold>A</bold>) Read count data for human islet bulk RNA-seq from GSE138748 was downloaded, processed, and matched with donor metadata. The dataset included 58 non-diabetic and 27 type 2 diabetic (T2D) samples. <bold>B</bold>) Human islet single-cell RNA-seq (scRNA-seq) count matrices were generated by realignment of reads and the datasets were integrated in Seurat. <bold>C</bold>) DEGAS transfers the bulk donor expression data and clinical trait information to individual cells in the single cell matrix for the purpose of prioritizing cells. This allows cells to be assigned scores which can then be thresholded for downstream analysis. <bold>D,E</bold>) Bulk RNA-seq data from Marselli et al. was analyzed by edgeR and displayed as both (<bold>D</bold>) volcano plot and (<bold>E</bold>) MA plot. Differentially expressed genes (DEGs) are those with p&lt;0.05 and &gt;1.5-fold changed and are highlighted in red. The MA plot in (<bold>E</bold>) provides a sense of relative transcript abundance among DEGs. <bold>F</bold>) Gene set enrichment analysis (GSEA) results for Hallmark_Inflammatory_Response show an enrichment for DEGs in T2D human islets. <bold>G</bold>) A simple comparison of up- and down-regulated genes in T2D human islets in RNA-seq data between Marselli et al. and Asplund et al. shows consistent findings. Significant DEGs from Marselli et al are outlined in black. <bold>H</bold>) DEGs from Marselli et al. that were also found on the Type 2 Diabetes Knowledge Portal database of known diabetes effector genes.</p></caption>
<graphic xlink:href="576260v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Human islet single-cell data acquisition, filtering, and integration</title>
<p>We obtained read count tables for five single-cell human islet datasets (GSE84133; GSE85241; E-MTAB-5061; GSE81608; GSE86469 (<bold>Table S1</bold>)) which were realigned to GRCh38.p5 (hg38) <sup><xref ref-type="bibr" rid="c8">8</xref></sup> (<bold><xref rid="fig1" ref-type="fig">Fig 1B</xref></bold>). Metadata were downloaded from GEO or obtained from the supplemental information of the respective publications. These five datasets were previously integrated and analyzed <sup><xref ref-type="bibr" rid="c8">8</xref></sup>. To prepare the data for our machine learning analyses, we repeated the integration and analysis of these datasets in R using Seurat to exclude cells with low expressed genes and cells with over 20% mitochondrial gene expression (low viability). The upper and lower limits varied between the datasets to account for differences in library preparation and sequencing platform following guidelines in the Seurat documentation.</p>
<p>Datasets were integrated into a single dataset using Seurat version 4.1.3, the Seurat objects were normalized using regularized negative binomial regression (SCTransform) to correct for batch effect and clustered using default settings. The most variable features were used to identify integration anchors which are passed to the IntegrateData function to return a Seurat object containing an integrated expression matrix of all cells.</p>
<p>The clusters were visualized using UMAP and expression of pancreatic hormone genes INS, GCG, SST, PPY, GHRL were used to annotate β, α, delta, γ and ε cell clusters, respectively. Clustering analysis used the Louvain algorithm <sup><xref ref-type="bibr" rid="c19">19</xref></sup> and labelling was performed to identify different cell types because our integrated dataset contained a mixture of cells from pancreatic islets. In total, 22 clusters were identified from 17,273 pancreatic cells and the clusters were classified into endocrine and non-endocrine cell types based on cell-specific marker expression (<bold><xref rid="fig2" ref-type="fig">Fig 2A</xref></bold>). R scripts are available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/kalwatlab/Islet_DEGAS_v1">https://github.com/kalwatlab/Islet_DEGAS_v1</ext-link>). The Seurat object containing all read count matrices and merged data and metadata is available on Mendeley<sup><xref ref-type="bibr" rid="c20">20</xref></sup>.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Validation of merged scRNA-seq datasets from five human islet studies.</title><p><bold>A</bold>) After integrating the five scRNA-seq datasets from <xref rid="fig1" ref-type="fig">Fig 1B</xref>, gene expression plots were created for the major endocrine and exocrine pancreas genes to demonstrate successful clustering of specific cell types. Metadata was overlaid onto single cell UMAP plots for show cex (<bold>B</bold>), BMI (<bold>C</bold>), age (<bold>D</bold>), and diabetes status (<bold>E</bold>).</p></caption>
<graphic xlink:href="576260v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Analyses</title>
<sec id="s3a">
<title>Differentially expressed genes from T2D bulk RNA-seq human islets show inflammatory signature and correlate with independent islet datasets</title>
<p>We selected bulk RNA-seq data from Marselli, et al. 2020 which contains 58 non-diabetic and 27 T2D samples with associated metadata for BMI, age, and sex <sup><xref ref-type="bibr" rid="c16">16</xref></sup> (<bold><xref rid="fig1" ref-type="fig">Fig 1A</xref>-<xref ref-type="fig" rid="fig1">C</xref></bold>). To determine the suitability of this data for DEGAS, we reanalyzed the read count matrix from GSE159984 using the edgeR likelihood ratio test to identify up- and down-regulated genes, visualized in both volcano (<bold><xref rid="fig1" ref-type="fig">Fig 1D</xref></bold>) and MD plot (<bold><xref rid="fig1" ref-type="fig">Fig 1E</xref></bold>, <bold><xref ref-type="fig" rid="figs1">Fig S1A</xref></bold>) formats to highlight fold-change versus significance and versus overall expression levels, respectively (<bold>Table S2</bold>). We observed altered expression of genes well-known to be dysregulated in T2D, including <italic>IAPP</italic> <sup><xref ref-type="bibr" rid="c21">21</xref>, <xref ref-type="bibr" rid="c22">22</xref></sup>, <italic>PAX4</italic> <sup><xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c24">24</xref></sup>, <italic>SLC2A2</italic> <sup><xref ref-type="bibr" rid="c25">25</xref></sup>, <italic>FFAR4</italic><sup><xref ref-type="bibr" rid="c26">26</xref></sup>, and <italic>ENTPD3</italic> <sup><xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c28">28</xref></sup> (<bold><xref rid="fig1" ref-type="fig">Fig 1D</xref>-<xref ref-type="fig" rid="fig1">E</xref></bold>).</p>
<p>Gene set enrichment analysis (GSEA) indicated that the gene expression profile of T2D human islets from this dataset was associated with an inflammatory response phenotype (<bold><xref rid="fig1" ref-type="fig">Fig 1F</xref></bold>). To compare our analysis of Marselli, et al. GSE159984 with an independent cohort, we selected a bulk RNA-seq human islet transcriptomic analysis from Asplund et al. <sup><xref ref-type="bibr" rid="c17">17</xref></sup>. Because the raw read count data from Asplund et al. is not accessible, we used the published supplementary table of log<sub>2</sub>-fold changes for differentially expressed genes and compared it with the Marselli dataset (<bold><xref rid="fig1" ref-type="fig">Fig 1G</xref></bold>) (<bold>Table S2</bold>). Significant differentially expressed genes from both Marselli and Asplund data included up-regulation of <italic>SFRP4</italic> and <italic>PODN</italic>, and down-regulation of <italic>UNC5D</italic> and <italic>FFAR4</italic> (<bold><xref ref-type="fig" rid="figs1">Fig S1B</xref></bold>). We also found substantial agreement in the directional changes of most other differentially expressed genes from both datasets, indicating that the Marselli islet data represents a suitable cohort for DEGAS analysis. Finally, we compared up- and down-regulated genes from T2D islets in the Marselli dataset with T2D effector genes from the T2D Knowledge Portal <sup><xref ref-type="bibr" rid="c29">29</xref></sup>. Down-regulated genes <italic>PAX4</italic> and <italic>SLC2A2</italic> and up-regulated genes <italic>APOE</italic> each have evidence of a strong or causal role in T2D at the genetic level, while <italic>CYTIP</italic> was up-regulated in T2D islets and has intron variant SNPs associated with T2D (e.g. rs13384965) <sup><xref ref-type="bibr" rid="c30">30</xref></sup> (<bold><xref rid="fig1" ref-type="fig">Fig 1H</xref></bold>).</p>
</sec>
<sec id="s3b">
<title>DEGAS revealed T2D-associated β-cells and marker genes within integrated human islet scRNA-seq data</title>
<p>We obtained five realigned scRNA-seq datasets <sup><xref ref-type="bibr" rid="c8">8</xref></sup> including Baron (GSE84133), Muraro (GSE85241), Segerstolpe (E-MTAB-5061), Lawlor (GSE86469), and Xin (GSE81608), and integrated them using Seurat 4.3.0 to subtype each of the major cell types for use with DEGAS. All five datasets were successfully integrated resulting in 17,273 cells (<bold><xref ref-type="fig" rid="figs2">Fig S2A</xref></bold>) and different cell types were clearly stratified from the scRNA-seq data (<bold><xref rid="fig2" ref-type="fig">Fig 2A</xref></bold>). Distinct clusters of cell types were enriched for their respective markers including β-cells (<italic>INS</italic>), α-cells (<italic>GCG</italic>), δ-cells (<italic>SST</italic>), ε-cells (<italic>GHRL</italic>), PP-cells (<italic>PPY</italic>), acinar cells (<italic>REG1A</italic>, <italic>PRSS1</italic>), ductal cells (<italic>KRT19</italic>, <italic>CFTR</italic>), stellate cells (<italic>COL6A1</italic>), endothelial cells (<italic>PLVAP</italic>), and mesenchymal cells (<italic>CD44</italic>) (<bold><xref rid="fig2" ref-type="fig">Fig 2A</xref></bold>).</p>
<p>Next, we implemented DEGAS <sup><xref ref-type="bibr" rid="c31">31</xref></sup>, a unique tool that leverages the increased sequencing depth, larger number of clinical covariates and sample sizes of bulk sequencing data. We used the deep learning architecture within DEGAS to project bulk islet sequencing data into the same latent representation as single cell islet data via domain adaptation. From this common latent representation, clinical covariates from the bulk sequencing data (e.g. T2D status and BMI) were projected onto single cells in a process called transfer learning. This process generates unitless disease-association scores for each single cell. After mapping the T2D-association scores to the single cell map (<bold><xref rid="fig3" ref-type="fig">Fig 3A</xref></bold>), we observed that β-cells had the lowest scores compared to other cell types (<bold><xref rid="fig3" ref-type="fig">Fig 3B</xref></bold>). This may be interpreted as reflecting fewer β-cells or lower insulin expression after onset of T2D <sup><xref ref-type="bibr" rid="c32">32</xref></sup>. We focused on differential T2D-association scores only among β-cells by subsetting them based on <italic>INS</italic> expression (<bold><xref rid="fig4" ref-type="fig">Fig 4A</xref></bold>) and superimposed the T2D-association scores onto each β-cell in the UMAP plot (<bold><xref rid="fig4" ref-type="fig">Fig 4B</xref></bold>). β-cells with higher scores (pink coloration) transcriptionally associate with human islet T2D expression profiles more than the lower scoring (black) β-cells. Next, we set quantile thresholds for the β-cell T2D-association scores and grouped the cells into high (upper 20%), medium and low (lower 20%) categories (<bold><xref rid="fig4" ref-type="fig">Fig 4C</xref></bold>). We compared the high versus low β<sup>T2D-DEGAS</sup> groups to genes enriched in either subset of β-cells (<bold><xref rid="fig4" ref-type="fig">Fig 4D</xref></bold>, <bold>Table S3)</bold>. High-scoring β<sup>T2D-DEGAS</sup> cells had elevated expression of <italic>CDKN1C</italic> (p57<sup>Kip<xref ref-type="bibr" rid="c2">2</xref></sup>) which binds and inhibits G1 cyclin/CDK complexes and is also involved in cellular sensescence <sup><xref ref-type="bibr" rid="c33">33</xref></sup> <sup><xref ref-type="bibr" rid="c34">34</xref></sup>, and reduced expression of <italic>IAPP</italic>, consistent with results from bulk T2D islet expression data (<bold><xref rid="fig1" ref-type="fig">Fig 1G</xref></bold>). These findings show that the DEGAS can successfully identify diabetes-relevant genes enriched in specific subclusters.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>DEGAS analysis based on T2D status.</title><p><bold>A</bold>) DEGAS T2D association scores (T2D-DEGAS) for each cell was overlaid onto the single cell UMAP plot. Higher scores in pink/red indicate a strong positive association and negative scores in darker black indicate a negative association of those cells with T2D. <bold>B)</bold> Violin plot displaying the aggregate T2D-DEGAS scores per cell type.</p></caption>
<graphic xlink:href="576260v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Identification of differentially-expressed genes in high- and low-scoring β<sup>T2D-DEGAS</sup> cell populations.</title><p><bold>A</bold>) β-cells were subsetted from all other cells based on <italic>INS</italic> expression and reclustered. <bold>B)</bold> DEGAS scores for T2D association (β<sup>T2D-DEGAS</sup>) were overlaid onto the cell plot. <bold>C)</bold> β-cells were classified as low, medium and high-scoring β<sup>T2D-DEGAS</sup> subpopulations for downstream analysis. <bold>D)</bold> Differential expression analysis of high vs. low β<sup>T2D-DEGAS</sup> scores. Genes with p&lt;0.05 and &gt;1.5-fold change are highlighted in red. <bold>E)</bold> Genes from (<bold>D</bold>) were filtered to remove DEGs that could be identified by comparing β-cells of T2D vs non-diabetic donors in the single cell data (<bold><xref ref-type="fig" rid="figs1">Fig S1D</xref></bold>). Gene ontology (GO) analysis of genes enriched in the high (<bold>F</bold>) and low (<bold>G</bold>) scoring β<sup>T2D-DEGAS</sup> subpopulations. <bold>H)</bold> GSEA results for high-vs. low-scoring β<sup>T2D-DEGAS</sup> subpopulations. <bold>I)</bold> Bubble plot highlighting genes driving GO and GSEA categories.</p></caption>
<graphic xlink:href="576260v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>As an additional way to highlight genes that were identified by DEGAS, we excluded genes that were differentially expressed between all non-diabetic (ND) and T2D β-cells (based on the merged scRNA-seq donor metadata <bold><xref ref-type="fig" rid="figs4">Fig S4D</xref>, Table S3</bold>). This process left over 90% of significant differentially expressed genes remaining which were only identified through DEGAS analysis (<bold><xref rid="fig4" ref-type="fig">Fig 4E</xref>)</bold>. This emphasizes the advantage of using DEGAS to generate continuous variables (disease-association scores) which enable thresholding and prioritizing cellular subpopulations. Gene ontology (GO) analysis on high-scoring β<sup>T2D-DEGAS</sup> cells showed enrichment in biological process categories including neutrophil degranulation, cell growth, and negative regulation of cell development (<bold><xref rid="fig4" ref-type="fig">Fig 4F</xref></bold>, <bold>Table S4</bold>). These categories were driven in part by immune-related genes (e.g. <italic>HLA-B</italic>, <italic>PSAP</italic>) and cell cycle regulator <italic>BTG1</italic>. Conversely, GO analysis on low-scoring β<sup>T2D-DEGAS</sup> cells showed enrichment of categories primarily related membrane protein targeting, translation, and mitochondrial electron transport (<bold><xref rid="fig4" ref-type="fig">Fig 4G</xref></bold>, <bold>Table S4</bold>). The top six enriched GO categories were driven largely by <italic>RPS</italic>/<italic>RPL</italic> genes. We also performed ranked-list GSEA on these same high-vs. low-scoring β<sup>T2D-DEGAS</sup> subpopulations which largely agreed with the GO analysis (<bold><xref rid="fig4" ref-type="fig">Fig 4H</xref></bold>). We observed significant positive enrichment for hypoxia, TNFα signaling, estrogen response, and glycolysis (<bold><xref ref-type="fig" rid="figs3">Fig S3D</xref></bold>), while significant negative enriched pathways included overlapping genes in oxidative phosphorylation and Myc-target pathways (<bold><xref ref-type="fig" rid="figs3">Fig S3E</xref></bold>). Examples of genes that drive the GO and GSEA categories are show (<bold><xref rid="fig4" ref-type="fig">Fig 4I</xref></bold>) and heterogeneity in the expression of these genes can be seen in β-cell UMAP plots (<bold><xref ref-type="fig" rid="figs3">Fig S3C</xref></bold>).</p>
</sec>
<sec id="s3c">
<title>β-cell clusters with high BMI-association scores (high β<sup>obese-DEGAS</sup>) show distinct differences between non-diabetic and T2D donors</title>
<p>Obesity and T2D are related, but not mutually inclusive. We surmised that obesity-association scores in β-cells may highlight unique subpopulations compared to the β<sup>T2D-DEGAS</sup> cells. Therefore, we categorized bulk RNA-seq donors by BMI (lean, &lt;25; overweight, 25-30; obese &gt;30) and ran the DEGAS analysis based on these categories to calculate BMI-association scores similar to our approach with T2D. Overlaying the BMI-DEGAS scores onto the islet single-cell data showed a distinct pattern of cell labeling between the obesity-association score (<bold><xref rid="fig5" ref-type="fig">Fig 5A</xref></bold>) compared to lean- or overweight-association scores (<bold><xref ref-type="fig" rid="figs5">Fig S5A</xref>,<xref ref-type="fig" rid="figs5">B</xref></bold>). It is interesting to note that the subpopulation of βlean-DEGAS cells appear to overlap with the subpopulation of low-scoring β<sup>T2D-DEGAS</sup> cells (<bold><xref ref-type="fig" rid="figs4">Fig S4C</xref></bold>), suggesting that single β-cells share features of low BMI and potentially lower T2D risk. The cell types with the highest obesity-association scores were β-cells, acinar cells, and stellate cells (<bold><xref rid="fig5" ref-type="fig">Fig 5B</xref></bold>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>DEGAS analysis based on obesity status.</title><p><bold>A</bold>) DEGAS obesity association scores (obese-DEGAS) for each cell was overlaid onto the single cell UMAP plot. Higher scores in pink/red indicate a strong positive association and negative scores in darker black indicate a negative association of those cells with obesity. <bold>B)</bold> Violin plot displaying the aggregate obese -DEGAS scores per cell type.</p></caption>
<graphic xlink:href="576260v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Reclustering β-cells with overlaid obesity-association scores enabled us to distinguish two major subpopulations of high-scoring β<sup>obese-DEGAS</sup> cells (<bold><xref rid="fig6" ref-type="fig">Fig 6A</xref></bold>), a feature that did not occur with β<sup>T2D-DEGAS</sup> cells (<bold><xref rid="fig4" ref-type="fig">Fig 4B</xref></bold>). We observed that a distinguishing difference between these two groups of obesity-associated β-cells was the donor diabetes status (ND vs T2D) in the single-cell metadata. We applied a median quantile threshold to extract these two subpopulations and classified the cell clusters based on their donor diabetes status to create ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> subpopulations (<bold><xref rid="fig6" ref-type="fig">Fig 6B</xref></bold>). We next determined differentially expressed genes between the ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> cells (<bold><xref rid="fig6" ref-type="fig">Fig 6C</xref></bold>). Gene ontology analysis of genes upregulated in the ND-β<sup>obese-DEGAS</sup> cluster indicated an enrichment for unfolded protein response (UPR)_ processes like vesicle transport, translation, and protein folding and stability (<bold><xref rid="fig6" ref-type="fig">Fig 6D</xref></bold>). Specifically, the ND-β<sup>obese-</sup> <sup>DEGAS</sup> cluster was enriched for expression of adaptive (e.g. <italic>MANF</italic> and <italic>HSPA5</italic>) and maladaptive (e.g. <italic>TRIB3</italic>, <italic>DDIT3</italic>) UPR genes, as well as genes involved in ER-associated degradation (e.g. <italic>SEL1L</italic>, <italic>DERL2</italic>, and <italic>SDF2L1</italic>). Gene ontology analysis of genes upregulated in the T2D-β<sup>obese-DEGAS</sup> cluster showed enrichment for hormone transport and secretion pathways (e.g. <italic>IGFBP5</italic>, <italic>UCN3</italic>, <italic>G6PC2</italic>) and inflammatory/immune-related pathways (e.g., <italic>HLA-A/B/E</italic>, <italic>STAT3</italic>) (<bold><xref rid="fig6" ref-type="fig">Fig 6E</xref></bold>). In parallel, we performed ranked-list GSEA on the ND- and T2D-β<sup>obese-</sup> <sup>DEGAS</sup> subpopulations which was largely consistent with gene ontology results (<bold><xref rid="fig6" ref-type="fig">Fig 6F</xref></bold>). Significantly enriched pathways for ND-β<sup>obese-</sup> <sup>DEGAS</sup> included the UPR and proliferation (E2F and MTORC signaling hallmarks) (<bold><xref ref-type="fig" rid="figs4">Fig S4I</xref></bold>), while T2D-β<sup>obese-</sup> <sup>DEGAS</sup> enriched pathways were similar to that of high-scoring β<sup>T2D-DEGAS</sup> cells and included hypoxia and glycolysis (<bold><xref ref-type="fig" rid="figs4">Fig S4J</xref></bold>). Examples of genes driving the GO and GSEA categories are shown, as well as <italic>CDKN1C</italic> and <italic>DLK1</italic>, given their differential enrichment in both β<sup>T2D-DEGAS</sup> and T2D-β<sup>obese-</sup> <sup>DEGAS</sup> cells (<bold><xref rid="fig6" ref-type="fig">Fig 6G</xref></bold>). The transcript heterogeneity for genes highlighted in <bold><xref rid="fig6" ref-type="fig">Fig 6G</xref></bold> can be observed in single β-cell expression plots (<bold><xref ref-type="fig" rid="figs4">Fig S4H</xref></bold>). Our results support the idea that these genes and pathways may underlie heterogeneity in β-cell resilience or susceptibility to obesity-related stress in the context of T2D development.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Two subpopulations of high β<sup>obese-DEGAS</sup> cells defined by underlying single cell donor T2D status uncovers stress signature in non-diabetic high-scoring obese-DEGAS β-cells.</title><p><bold>A</bold>) β-cells were subsetted from <xref rid="fig5" ref-type="fig">Fig 5A</xref> based on <italic>INS</italic> expression and obese-DEGAS scores overlaid onto the single cells. <bold>B)</bold> β-cells were further subsetted based on both their high obese-DEGAS scores and by the underlying T2D status of the single cell donors, leading to two major subpopulations, ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> cells. <bold>C)</bold> Differential expression analysis comparing ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> subpopulations. Genes with p&lt;0.05 and &gt;1.5-fold change are highlighted in red. Gene ontology (GO) analysis of genes enriched in the ND-β<sup>obese-DEGAS</sup> (<bold>D</bold>) and T2D-β<sup>obese-DEGAS</sup> (<bold>E</bold>) subpopulations. <bold>F)</bold> Gene set enrichment analysis (GSEA) of ND-vs. T2D-β<sup>obese-DEGAS</sup> subpopulations. <bold>G)</bold> Bubble plot highlighting genes driving GO and GSEA categories.</p></caption>
<graphic xlink:href="576260v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s3d">
<title>DLK1 is a candidate identified in β<sup>T2D-DEGAS</sup> and ND-β<sup>obese-DEGAS</sup> cells and is heterogeneously expressed among diabetic and non-diabetic human pancreatic islets</title>
<p>To support the DEGAS approach for identifying true markers of β-cell subpopulations or heterogeneity associated with diabetes, we selected a candidate gene for immunostaining in FFPE human pancreas sections from non-diabetic and T2D donors. The subpopulations of cells for both β<sup>T2D-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> exhibited a subset of overlapping enriched genes. One of the more interesting candidates we noted was <italic>DLK1</italic> (Delta-Like 1 Homolog), which is known to have strong associations with T1D <sup><xref ref-type="bibr" rid="c35">35</xref></sup> and T2D <sup><xref ref-type="bibr" rid="c36">36</xref></sup>. <italic>DLK1</italic> expression highly overlapped with high scoring β<sup>T2D-</sup> <sup>DEGAS</sup> cells (<bold><xref rid="fig7" ref-type="fig">Fig 7A</xref></bold>) and with T2D-β<sup>obese-DEGAS</sup> cells (<bold><xref rid="fig7" ref-type="fig">Fig 7B</xref></bold>). DLK1 immunostaining primarily colocalized with β-cells in non-diabetic human pancreas (<bold><xref rid="fig7" ref-type="fig">Fig 7C</xref></bold>). DLK1 showed heterogeneous expression within islets and between islets within the same pancreas section, wherein some islets had DLK1/INS co-staining in most β-cells and other islets had only a few DLK1<sup>+</sup> β-cells. In T2D pancreas, DLK1 staining was much less intense and in fewer β-cells, yet DLK1<sup>+</sup>/INS<sup>+</sup> cells were observed (<bold><xref rid="fig7" ref-type="fig">Fig 7C</xref></bold>). This contrasts with the relatively higher <italic>DLK1</italic> gene expression seen in the β-cells from the β<sup>T2D-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> subpopulations (<bold><xref rid="fig4" ref-type="fig">Fig 4D</xref> &amp; <xref ref-type="fig" rid="fig6">6C</xref></bold>) as highlighted in <bold><xref rid="fig7" ref-type="fig">Fig 7A</xref>,<xref ref-type="fig" rid="fig7">B</xref></bold>.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>DLK1 is a β-cell gene heterogeneously expressed between cells and islets of non-diabetic and T2D humans.</title><p><bold>A</bold>) Formalin-fixed paraffin-embedded (FFPE) sections of human pancreas from non-diabetic (ND) and T2D donors was stained for INS and DLK1. Representative images are shown from three different ND and T2D donors. Arrows indicate INS<sup>+</sup>/DLK1<sup>+</sup> cells. <bold>B)</bold> UMAP plot overlaying DLK1 expression and βT2D-DEGAS (<bold>i</bold>) or βobese-DEGAS (<bold>ii</bold>) scores.</p></caption>
<graphic xlink:href="576260v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<sec id="s4a">
<title>Deep transfer learning is a useful approach to identify disease-associated genes in subsets of heterogeneous islet cells</title>
<p>The rapid advancement of deep learning has unveiled new opportunities in diabetes research, specifically the ability to merge and analyze the large amount of publicly available omics data. The DEGAS deep transfer learning framework provides an extremely powerful and versatile tool allowing for time to event outcomes and classification outcomes to be transferred to individual cells. Notably, this direct transfer to single cells avoids the cluster resolution problems that arise using deconvolution approaches, allowing for subsets of cells within a cluster to be assigned different associations with clinical outcomes. In this way, DEGAS allows the definition of essentially new cell subpopulations that would not necessarily be identified by standard clustering algorithms and these subpopulations are rationally selected based on assigned disease association scores. A key point from our study is that the disease-associated single cells identified by DEGAS are those cells whose transcriptomic signature share complex patterns with patient transcriptomics that have known clinical and metabolic attributes. Because of this, the genes identified as up-or down-regulated in subsets of β-cells may be: 1) altered independent of disease due to genetic background of donors; 2) altered downstream of the obese or diabetic states; or 3) representative of resilient or dysfunctional β-cells in the face of metabolic syndrome. Through careful cohort inclusion criteria and batch effect removal, our analyses aim to limit these caveats when possible.</p>
<p>Various deconvolution methods enable estimating relative proportions of cell types in bulk samples using scRNA-seq data (e.g. BSEQ-sc <sup><xref ref-type="bibr" rid="c1">1</xref></sup>, MuSiC <sup><xref ref-type="bibr" rid="c37">37</xref></sup>, CIBERSORT <sup><xref ref-type="bibr" rid="c38">38</xref></sup>, and DWLS <sup><xref ref-type="bibr" rid="c39">39</xref></sup>). These methods have been instrumental in identifying changes to relative quantity of cell types within normal and disease tissues; however, they do not provide detailed information about subsets of cell types which may be related to disease and are limited to the resolution of the predefined cell types through clustering. Early attempts to address this include unsupervised learning algorithms (e.g. RaceID) <sup><xref ref-type="bibr" rid="c40">40</xref></sup>. Now, there are multiple advanced computational approaches to identify subsets of cells related to disease status, survival, drug response, and other disease metrics. These tools can be broadly categorized as ‘cell prioritization algorithms’ and include: DEGAS <sup><xref ref-type="bibr" rid="c31">31</xref></sup>, scAB <sup><xref ref-type="bibr" rid="c41">41</xref></sup>, Scissor <sup><xref ref-type="bibr" rid="c42">42</xref></sup>, and scDEAL <sup><xref ref-type="bibr" rid="c43">43</xref></sup>. Scissor and scAB can assign survival or clinical information from bulk expression data to disparate scRNA-seq datasets using regression and matrix factorization, respectively. scDEAL is a deep learning framework specifically designed for the assignment of drug response information from bulk expression data to subsets of single cells. The major advantages of DEGAS are 1) the ability to select subsets of β-cells at an individual cell resolution based on their disease association; 2) unique qualities of the highly non-linear DEGAS technology vs. linear models of other tools to detect complex molecular programs; and 3) speed and scalability based on efficient implementation. DEGAS has the potential to be used on datasets containing well over 1 million cells, unlike other methods.</p>
<p>Nevertheless, certain linear model-based approaches, like RePACT (regressing principal components for the assembly of continuous trajectory), have successfully uncovered genes associated with β-cell heterogeneity in T2D and obesity <sup><xref ref-type="bibr" rid="c5">5</xref></sup>. In that study, T2D and obesity ‘trajectory’ genes were identified. We compared the genes enriched in our high-scoring β<sup>T2D-DEGAS</sup> and in our T2D-β<sup>obese-DEGAS</sup> cells with the corresponding T2D and obesity trajectory genes from Fang et al., respectively (<bold><xref ref-type="fig" rid="figs5">Fig S5</xref></bold>, <bold>Table S5</bold>). We noted substantial agreement between DEGAS and RePACT, for example the transcription factor SIX3 was enriched in T2D-β<sup>obese-DEGAS</sup> cells and in Fang et al.’s obese trajectory β-cells <sup><xref ref-type="bibr" rid="c5">5</xref></sup>. SIX3 has been implicated as a diabetes risk gene and is important for β-cell function <sup><xref ref-type="bibr" rid="c44">44</xref>, <xref ref-type="bibr" rid="c45">45</xref></sup>. Additionally, both approaches highlighted the association of DLK1 with obesity, but only DEGAS identified DLK1 association with T2D. Overall, the directionality of T2D or obesity gene associations agreed between DEGAS and RePACT results. However, not all the same genes were identified by both approaches, for example, FXYD2 was identified via RePACT, but not in DEGAS, although FXYD2 is a down-regulated gene in T2D in Marselli et al. and Asplund et al. (<bold><xref rid="fig1" ref-type="fig">Fig 1G</xref></bold>). Interestingly, FXYD2 has was recently shown to be a downstream effector gene of HNF1A in single human β-cells <sup><xref ref-type="bibr" rid="c46">46</xref></sup>. Down-regulation of HNF1A in T2D β-cells, and reduced FXYD2 expression as a result, may contribute to membrane hyperpolarization and reduced function <sup><xref ref-type="bibr" rid="c46">46</xref></sup>. Distinct from the application of RePACT in Fang, et al.<sup><xref ref-type="bibr" rid="c5">5</xref></sup>, we did not observe any differences in HNF1A expression in our DEGAS analyses and FXYD2 was slightly enriched, but not significantly altered, in T2D-β<sup>obese-</sup> <sup>DEGAS</sup> cells. Taken together, it is necessary to apply multiple approaches to merged sets of publicly available data because each approach will likely uncover unique and important subsets of β-cells or specific genes.</p>
</sec>
<sec id="s4b">
<title>Differences between high- and low-scoring β<sup>T2D-DEGAS</sup> subpopulations</title>
<p>High-scoring β<sup>T2D-DEGAS</sup> cells had enrichment of pathways like hypoxia and TNFα signaling which contain some overlapping genes like <italic>BTG1</italic>, <italic>BTG2</italic>, and <italic>BHLHE40</italic>. <italic>BHLHE40</italic> was recently shown to cause hypoxia-induced β-cell dysfuction via interfering with <italic>MAFA</italic> expression <sup><xref ref-type="bibr" rid="c47">47</xref></sup>. <italic>BTG1</italic> and <italic>BTG2</italic> are known as anti-proliferation factors. Given the expression of both <italic>BTG1</italic> and <italic>CDKN1C</italic> in high-scoring β<sup>T2D-DEGAS</sup> cells, it is possible these cells have very low proliferative potential, even in the context of β-cells which are well-known to have low proliferation. Although some genes like <italic>CDKN1C</italic> can be identified as differentially expressed in simple comparisons of all T2D vs ND donor β-cells in scRNA-seq data, DEGAS has the advantage of prioritization or ranking of candidates. For example, <italic>CDKN1C</italic> is within the top ten enriched candidates (by adjusted P value and fold-change) in the β<sup>T2D-DEGAS</sup> cluster but is 286<sup>th</sup> when simply comparing all T2D vs ND single β-cells (<bold>Table S3</bold>). Additionally, deletion of <italic>CDKN1C</italic> has been shown to improve human islet function <sup><xref ref-type="bibr" rid="c48">48</xref></sup> and gain-of-function mutants are associated with diabetes development and hyperinsulinism <sup><xref ref-type="bibr" rid="c49">49</xref>, <xref ref-type="bibr" rid="c50">50</xref></sup>.</p>
<p>The low-scoring β<sup>T2D-DEGAS</sup> cells were enriched in pathways involving oxidative phosphorylation and Myc targets. We also noted enrichment of many small and large ribosomal genes (<italic>RPS</italic>/<italic>RPL</italic>) in this subpopulation. <italic>RPS</italic>/<italic>RPL</italic> ribosomal genes are known to be highly expressed in primary human β-cells <sup><xref ref-type="bibr" rid="c51">51</xref></sup>, and glucose stimulation induced translation of over 50 different <italic>RPS</italic>/<italic>RPL</italic> genes in human β-cell line EndoC-βH2 <sup><xref ref-type="bibr" rid="c52">52</xref></sup>. This suggest that low-scoring β<sup>T2D-DEGAS</sup> cells may have relatively increased translation and metabolic activity. Taken together, high-scoring β<sup>T2D-DEGAS</sup> cells may be reflective of dysfunctional β-cells in either a pre-T2D or T2D-onset state, while low-scoring β<sup>T2D-DEGAS</sup> cells could potentially represent more resilient β-cells.</p>
</sec>
<sec id="s4c">
<title>Differences between ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> subsets of β-cells</title>
<p>Our understanding of why some individuals with obesity develop T2D while others do not is incomplete. A 2021 NHANES report indicated a 41.9% prevalence for obesity in US adults aged 20 and over, with a 14.8% prevalence for diabetes <sup><xref ref-type="bibr" rid="c53">53</xref></sup>, in line with CDC reports <sup><xref ref-type="bibr" rid="c54">54</xref></sup>. This suggests that many individuals with obesity have either not progressed, or may never progress, to T2D. This phenomenon may be related to those individuals categorized as metabolically healthy obese as compared to metabolically unhealthy obese <sup><xref ref-type="bibr" rid="c55">55</xref></sup>. Expanded work with DEGAS may uncover specific genes that underly this relationship. In our analysis we were able to stratify based on T2D status of the single cell donors and overlay the relative obesity-association scores from DEGAS. That analysis allowed us to set rational thresholds for grouping subsets of β-cells to compare ND- and T2D-β<sup>obese-DEGAS</sup> cells. Perhaps counterintuitively, UPR genes were highly enriched in the ND-β<sup>obese-DEGAS</sup> cells as opposed to the T2D-β<sup>obese-</sup> <sup>DEGAS</sup> cells. It is possible these ND-β<sup>obese-DEGAS</sup> cells are in a stressed pre-diabetic state on the path to T2D. Dominguez-Gutierrez et al. analyzed islet scRNA-seq data using pseudotime analysis and identified three major β-cell states which were defined by their insulin expression and UPR level <sup><xref ref-type="bibr" rid="c56">56</xref></sup>. The authors speculate that β-cells periodically pass through these states, which in scRNA-seq are visualized as subpopulations of cells. Previously, a <italic>FTH1</italic> subpopulation of β-cells was identified with implications in the UPR <sup><xref ref-type="bibr" rid="c57">57</xref></sup>. In agreement with those results, we found <italic>FTH1</italic> was upregulated in ND-β<sup>obese-DEGAS</sup> cells. Therefore, another possibility is that the UPR induced in ND-β<sup>obese-DEGAS</sup> cells marks a population with lower functionality but higher proliferative potential to combat the insulin resistant obese state, and the relatively lower UPR in T2D-β<sup>obese-DEGAS</sup> cells possibly correlates with enhanced functionality in established T2D. Concordantly, T2D-β<sup>obese-DEGAS</sup> cells had enrichment of hormone secretion genes (e.g. <italic>SYT7, G6PC2, NEUROD1, UCN3</italic>, <italic>FFAR1</italic>) in our pathway analysis (<bold><xref rid="fig6" ref-type="fig">Fig 6E,F</xref></bold>). In a study of human, mouse, and pig islet scRNA-seq data, subpopulations of ‘stressed’ β-cells were identified that exhibited enriched hallmark pathways similarly to what we observe in ND-β<sup>obese-DEGAS</sup> cells <sup><xref ref-type="bibr" rid="c6">6</xref></sup>. Thus, multiple studies including our current analysis support the existence of subpopulations of stressed β-cells, whether transient or stable, that could in principle be targeted by therapeutics.</p>
<p>We also looked for enrichment of potential secreted biomarkers in high-scoring β<sup>T2D-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> cells and identified <italic>LRPAP1</italic> and <italic>C1QL1</italic>. <italic>LRPAP1</italic> encodes the LDL receptor-related protein-associated protein 1 (LRPAP) and is enriched in this subpopulation. LRPAP is ubiquitously expressed and is predicted to be an ER resident protein <sup><xref ref-type="bibr" rid="c58">58</xref></sup>. LRPAP appears to be heterogeneously expressed among islet cells and was detected in human plasma in the in the Human Protein Atlas <sup><xref ref-type="bibr" rid="c59">59</xref></sup>. <italic>C1QL1</italic> encodes a secreted peptide that is highly-expressed in human islets <sup><xref ref-type="bibr" rid="c60">60</xref></sup> and was enriched in β<sup>T2D-DEGAS</sup> cells, although little else is known about its role in β-cells. Increased C1QL1 release could potentially signal through its GPCR BAI3 to suppress insulin secretion of surrounding β-cells, as has been shown for C1QL3 <sup><xref ref-type="bibr" rid="c61">61</xref></sup>.</p>
</sec>
<sec id="s4d">
<title>Potential for DEGAS in identifying β-cell heterogeneity markers</title>
<p>Subsets or subpopulations of β-cells are an emergent property of β-cell heterogeneity. Two of the most widely used scRNA-seq datasets have also identified significant heterogeneity within pancreatic cell types, notably β-cells <sup><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c57">57</xref></sup>. Various markers have been identified to define these β-cell subpopulations, including expression of ST8SIA1 and CD9 <sup><xref ref-type="bibr" rid="c62">62</xref></sup> or Flattop expression <sup><xref ref-type="bibr" rid="c63">63</xref></sup>. Additionally, UCN3 marks mature β cells <sup><xref ref-type="bibr" rid="c64">64</xref></sup> and RBP4<sup>+</sup> β-cells correlated with reduced function <sup><xref ref-type="bibr" rid="c65">65</xref></sup>. Functional heterogeneity has also been described as in the case of leader/first-responder β cells <sup><xref ref-type="bibr" rid="c66">66</xref>, <xref ref-type="bibr" rid="c67">67</xref></sup> or hub β cells <sup><xref ref-type="bibr" rid="c68">68</xref></sup>, and has been linked to transcription factors including PDX1<sup><xref ref-type="bibr" rid="c69">69</xref></sup> and HNF1A <sup><xref ref-type="bibr" rid="c46">46</xref></sup>. Nevertheless, cellular heterogeneity within a single cell type is complicated and there is uncertainty in the single cell analytics field about what constitutes a stable cell type versus a transient cell state <sup><xref ref-type="bibr" rid="c70">70</xref></sup>. Tying transcriptionally distinct clusters to function or morphology may be key to making this distinction <sup><xref ref-type="bibr" rid="c71">71</xref></sup>. By inferring disease outcomes in high resolution cellular subtypes, application of DEGAS can help to inform this debate.</p>
<p>In our analysis, <italic>DLK1</italic> expression was enriched in high-scoring β<sup>T2D-DEGAS</sup> and in T2D-β<sup>obese-DEGAS</sup> cells. We also observed heterogeneous DLK1 staining of β-cells from human pancreas sections. <italic>DLK1</italic> was previously noted to be enriched in subpopulations of β-cells <sup><xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c72">72</xref></sup>, however its heterogeneity in transcript and protein abundance in non-diabetic versus T2D human islet β-cells had not been described until now. DLK1 is a maternally-imprinted gene<sup><xref ref-type="bibr" rid="c73">73</xref></sup> with described roles in Notch signaling<sup><xref ref-type="bibr" rid="c74">74</xref>–<xref ref-type="bibr" rid="c76">76</xref></sup> and glucose homeostasis<sup><xref ref-type="bibr" rid="c77">77</xref></sup>. Supporting an active role β-cell disease, a recent preprint reported DLK1 was required for proper maturation, function, and stress resilience of β-like cells differentiated from human embryonic stem cells <sup><xref ref-type="bibr" rid="c78">78</xref></sup>. Our results combined with the published data indicate DLK1 as a significant player in β-cell function in diabetes. DLK1 may serve as a surface marker of, or be released from, stressed or at-risk β-cells. However, increased sample sizes and in-depth analyses of both non-diabetic, T1D, and T2D human islets will be required to better describe the differences seen in transcript and protein abundance of DLK1 between β-cells within the same islet, between islets of the same and different donors, and across different stages of diabetes development.</p>
<p>Applying tools like DEGAS to available data will increase our understanding of the underlying β-cell features associated with progression to T2D or with an obese non-T2D state. Expanded DEGAS analyses will be needed to include scRNA-seq data from islets subjected to various models of T1D/T2D (e.g. cytokines, glucolipotoxicity). Major questions include whether the gene candidates identified by DEGAS are protective, disease-causing, or simply markers in β-cell subpopulations. In the future, these questions may be addressed by functional validation studies or observations in genome-wide association studies.</p>
</sec>
<sec id="s4e">
<title>Limitations of the study and future directions</title>
<p>We think the approach of joining islet omics data to deep learning and artificial intelligence is an area in need of increased attention; however, we appreciate that our current study has limitations. First, our analysis utilized a single bulk RNA-seq human islet dataset, although the Marselli study contains a relatively large number of islet donors compared to most available datasets. Second, we merged only five scRNA-seq human islet datasets for this application of DEGAS. The datasets were chosen because of the extensive meta-analyses to which they have already been subjected <sup><xref ref-type="bibr" rid="c8">8</xref></sup>, and their use as benchmarking data in many scRNA-seq analysis tools <sup><xref ref-type="bibr" rid="c79">79</xref>–<xref ref-type="bibr" rid="c81">81</xref></sup>. scRNA-seq has a limitation on the number of detectable genes in each cell, as compared to bulk RNA-seq samples. While these limitations may eventually be mitigated by improved technologies, we can begin to overcome these by merging a larger number of human islet bulk and scRNA-seq studies which contain more donors. Increased sample sizes and study variables come with their own challenges, however the future gene candidates identified by DEGAS will be of even higher confidence. Additionally, scRNA-seq is a snapshot in time and it may be tenuous to claim that a particular cell state is transient or persistent. To support a claim that a given subset/subtype of β-cells represents an actual stable population in scRNA-seq data requires at least finding that the cells comprising the candidate population occur across multiple individual donors. In future studies, our use of the diabetes field’s considerable investment in islet transcriptomics data and state-of-the-art cell prioritization tools will enable simultaneous identification of disease-associated cellular subtypes and associated biomarkers of function and dysfunction. Additionally, increasing the number of human pancreas donor tissue samples for high-content image analysis will improve confidence in candidate gene validation.</p>
</sec>
</sec>
<sec id="s5">
<title>Potential implications</title>
<p>DEGAS has the potential to be applied to even larger mergers of single cell data (&gt; 1 million cells) using the newly developed DEGAS atlas implementations. A vast amount of human (and other species) islet single cell transcriptomics data is publicly available, but often requires substantial reformatting of metadata and realigning of reads to be harmonized. As our endeavors and those of others proceed, DEGAS will lead to even higher confidence predictions of β-cell subpopulations. It is also apparent from our DEGAS analyses that other non-β-cells are highlighted in the islet single cell map for associations with T2D and obesity. Although outside the scope of this work, further exploration of our current DEGAS analyses, or of analyses using larger single cell integrations, will have implications for the other major islet and pancreas cell types, including α-cells, δ-cells and PP-cells. For example, PP cells have been shown to have a role in pancreatogenic diabetes as opposed to T2D <sup><xref ref-type="bibr" rid="c82">82</xref></sup>, and there appear to be subpopulations of high and low scoring PP<sup>T2D-DEGAS</sup> cells within the DEGAS analysis (<bold><xref rid="fig3" ref-type="fig">Fig 3A</xref></bold>). Our successful application of deep transfer learning in human islet data opens the possibility of predicting subtypes of β-cells in other diseases, like T1D and congenital hyperinsulinism, to find potential biomarkers and therapeutic candidates. In some rare disease, like congenital hyperinsulinism, single cell data is not available, however spatial transcriptomics (ST) could be applied to FFPE sections. DEGAS has already been implemented to analyze ST data in prostate cancer <sup><xref ref-type="bibr" rid="c83">83</xref></sup>, and will be applicable to human pancreas as ST technology continues to advance. It is important to note that DEGAS is just one of many machine learning approaches to analyze transcriptomic data. It will be important to include DEGAS in combination with both linear and other non-linear models to capture as many relevant gene candidates as possible.</p>
</sec>
<sec id="s6">
<title>Methods</title>
<sec id="s6a">
<title>Transfer learning using DEGAS on human islet transcriptomic data</title>
<p>The integrated single cell and bulk datasets were processed with the DEGAS (v1.0) pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/tsteelejohnson91/DEGAS">https://github.com/tsteelejohnson91/DEGAS</ext-link>) <sup><xref ref-type="bibr" rid="c31">31</xref></sup> to calculate disease risk scores associated with T2D status or BMI status. The bulk expression data were scaled and normalized prior to DEGAS analysis using the preprocessCounts function. The merged scRNA-seq expression matrix, the bulk expression matrix, and donor sample labels (matched with the bulk samples) were used as input. The intersection of highly variable genes between scRNA-seq and bulk expression data were used for further analysis. The DEGAS model was trained and predicted on the formatted data. Updated scripts and instructions for running DEGAS are available on GitHub (version 1.0) (<ext-link ext-link-type="uri" xlink:href="https://github.com/tsteelejohnson91/DEGAS">https://github.com/tsteelejohnson91/DEGAS</ext-link>). DEGAS for T2D and BMI were run independently.</p>
<p>In DEGAS for T2D, the donor labels were “normal” vs “T2D.” In DEGAS for BMI metadata, donors from bulk RNA-seq were categorized and labeled as “lean” (&lt;25 BMI), “overweight” (25-30 BMI) and “obese” (&gt;30 BMI) according to CDC guidelines. The models were trained to calculate T2D-association scores and BMI-association scores for each of the respective categories. We identified differentially-expressed genes using FindMarkers function in β-cells with high vs low T2D-association scores (β<sup>T2D-DEGAS</sup>) or high obesity scores (β<sup>obese-DEGAS</sup>) among healthy or T2D donor single-cells.</p>
</sec>
<sec id="s6b">
<title>Subclustering of β-cells and post-DEGAS scRNA-seq analysis</title>
<p>We isolated the β-cell cluster using subset function and reclustered them seperately from the other islet cell types. The β-cells were further classified by different thresholding parameters including median and quantiles. For quantile and median thresholds, we generated high, medium and low, as well upper 50% and lower 50% of median. We used the FindMarkers function to identify differentially-expressed genes in high vs. low (<bold><xref rid="fig4" ref-type="fig">Fig 4D</xref></bold>), high vs. medium+low, and median (upper 50% vs lower 50%) <bold>(Table S3)</bold>.</p>
</sec>
<sec id="s6c">
<title>Pathway analysis</title>
<p>To analyze differentially-expressed genes that were either up- or down-regulated between clusters, enrichment analyses and plot generation were completed using ClusterProfiler, EnhancedVolcano, and ggplot2 R packages in R version 4.2.2 and RStudio. Enrichment of gene sets within the the Biological Process GO terms are shown and cluster profiler outputs are provided in <bold>Table S4</bold>. Venn diagrams for comparing DEGAS and RePACT hit genes (<bold>Table S5</bold>) were created using <ext-link ext-link-type="uri" xlink:href="https://molbiotools.com/listcompare.php">https://molbiotools.com/listcompare.php</ext-link>. Gene set enrichment analysis was run using GSEA software <sup><xref ref-type="bibr" rid="c84">84</xref>, <xref ref-type="bibr" rid="c85">85</xref></sup> downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea">www.gsea-msigdb.org/gsea</ext-link> and the MSigDB Hallmark Gene Set <sup><xref ref-type="bibr" rid="c86">86</xref></sup> from the Broad Institute. For bulk RNA-seq analysis, the edgeR results containing all expressed genes was used as input to run standard GSEA. For GSEA analysis of comparisons between subpopluations of β-cells from scRNA-seq data, a ranked list based on log<sub>2</sub>fold-change was generated without a cutoff for adjusted P value. GSEAPreranked mode used the ’classic’ enrichnment statistic for 1000 permutations.</p>
</sec>
<sec id="s6d">
<title>Human pancreas tissue staining and microscopy</title>
<p>Formalin-fixed paraffin-embedded (FFPE) de-identified human pancreas tissue were obtained through the NDRI (<bold>Table S6</bold>). Tissue was processed into 5 µm sections and mounted on glass slides by the Indiana University School of Medicine Histology Lab Service Core. Slides were deparaffinized by xylene and ethanol washes. Antigen retrieval was performed by heating for 40 min in an Epitope Retrival Steamer with slides submerged in Epitope Retrieval Solution (IHC-Tek). Subsequently, slides were placed onto disposable immunostaining coverplates and inserted into the Sequenza slide rack (Ted Pella / EMS) for washing, blocking, and antibody incubations. After three 10 min washes in IHC wash buffer (0.1% Triton X-100 and 0.01% sodium azide in PBS pH 7.4), slides were blocked for 1 h at room temperature in normal donkey serum (NDS) block solution (5% donkey serum, 1% bovine serum albumin, 0.3% Triton X-100, 0.05% Tween-20, and 0.05% sodium azide in PBS pH 7.4). Slides were then incubated overnight at 4°C with primary antibodies diluted in NDS block solution (<bold>Table S7</bold>). After three washes in IHC wash buffer 200 µL each), slides were incubated in secondary antibodies in NDS block solution for 1 h at room temperature. The washed slides were mounted in polyvinyl alcohol (PVA) mounting medium (5% PVA, 10% glycerol, 50mM Tris pH 9.0, 0.01% sodium azide) with DAPI (300 nM) added and imaged on Zeiss LSM710 confocal microscope equipped with a Plan-Apochromat 20x/0.8 objective (#420650-9901). Images were processed in the Zeiss Zen software to add scale bars, set coloration for channels, and generate merged images. Scale bars indicate 50 µm.</p>
</sec>
<sec id="s6e">
<title>Statistical Analysis</title>
<p>In edgeR bulk RNAseq differential gene expression analysis, the likelihood ratio test was applied. In the FindMarkers function in Seurat the default Wilcoxon Rank Sum test was used for differential gene expression analysis. Cut-offs for signifcant differentially expressed genes were set at |log<sub>2</sub>fold-change| &gt; 0.58 and adjusted p-value &lt; 0.05.</p>
</sec>
</sec>

<sec id="d1e1790" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1898">
<label>Table S1</label>
<media xlink:href="supplements/576260_file03.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1905">
<label>Table S2</label>
<media xlink:href="supplements/576260_file04.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1912">
<label>Table S3</label>
<media xlink:href="supplements/576260_file05.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1919">
<label>Table S4</label>
<media xlink:href="supplements/576260_file06.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1927">
<label>Table S5</label>
<media xlink:href="supplements/576260_file07.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1934">
<label>Table S6</label>
<media xlink:href="supplements/576260_file08.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e1941">
<label>Table S7</label>
<media xlink:href="supplements/576260_file09.xlsx"/>
</supplementary-material>
</sec>
</body>
<back>
<sec id="s7">
<title>Availability of source code and requirements</title>
<list list-type="bullet">
<list-item><p>Project name: Islet DEGAS</p></list-item>
<list-item><p>Project home page: <ext-link ext-link-type="uri" xlink:href="https://github.com/kalwatlab/Islet_DEGAS_v1">https://github.com/kalwatlab/Islet_DEGAS_v1</ext-link></p></list-item>
<list-item><p>Operating system(s): Platform independent</p></list-item>
<list-item><p>Programming language: R and Python</p></list-item>
<list-item><p>Other requirements: not applicable</p></list-item>
<list-item><p>License: ©</p></list-item>
</list>
</sec>
<sec id="s8">
<title>Data availability</title>
<p>The raw data sets supporting the results of this article are available in the NCBI GEO and the ArrayExpress repositories under the following persistent identifiers (also shown in <bold>Table S1</bold>): bulk RNA-seq: GSE159984; scRNA-seq: GSE84133, GSE85241, GSE86469, E-MTAB-5061, GSE81608.</p>
</sec>
<sec id="s9">
<title>Declarations</title>
</sec>
<glossary>
<title>List of abbreviations</title>
<def-list>
<def-item>
<term>ND</term>
<def><p>non-diabetic</p></def>
</def-item>
<def-item>
<term>T1D</term>
<def><p>type 1 diabetes</p></def>
</def-item>
<def-item>
<term>T2D</term>
<def><p>type 2 diabetes</p></def>
</def-item>
<def-item>
<term>RNA-seq</term>
<def><p>RNA sequencing</p></def>
</def-item>
<def-item>
<term>scRNA-seq</term>
<def><p>single cell RNA sequencing</p></def>
</def-item>
<def-item>
<term>FFPE</term>
<def><p>formalin-fixed paraffin-embedded</p></def>
</def-item>
<def-item>
<term>DEGAS</term>
<def><p>Diagnostic Evidence GAuge of Single cells</p></def>
</def-item>
<def-item>
<term>DLK1</term>
<def><p>Delta Like Non-Canonical Notch Ligand 1</p></def>
</def-item>
<def-item>
<term>MANE</term>
<def><p>Matched Annotation from NCBI and EBI</p></def>
</def-item>
<def-item>
<term>RRID</term>
<def><p>Research Resource identifer</p></def>
</def-item>
<def-item>
<term>GSEA</term>
<def><p>gene set enrichment analysis</p></def>
</def-item>
<def-item>
<term>MSigDB</term>
<def><p>Molecular signatures database</p></def>
</def-item>
<def-item>
<term>BMI</term>
<def><p>body mass index</p></def>
</def-item>
<def-item>
<term>UMAP</term>
<def><p>uniform manifold approximation and projection</p></def>
</def-item>
<def-item>
<term>β<sup>T2D-DEGAS</sup></term>
<def><p>T2D-DEGAS disease assocation score for beta cells</p></def>
</def-item>
<def-item>
<term>β<sup>obese-DEGAS</sup></term>
<def><p>obese-DEGAS disease assocation score for beta cells</p></def>
</def-item>
<def-item>
<term>ND-β<sup>obese-DEGAS</sup></term>
<def><p>obese-DEGAS disease assocation score for beta cells from ND donors</p></def>
</def-item>
<def-item>
<term>T2D-β<sup>obese-DEGAS</sup></term>
<def><p>obese-DEGAS disease assocation score for beta cells from T2D donors</p></def>
</def-item>
<def-item>
<term>GO</term>
<def><p>gene ontology</p></def>
</def-item>
<def-item>
<term>RePACT</term>
<def><p>regressing principle components for the assembly of continuous trajectory</p></def>
</def-item>
<def-item>
<term>NDS</term>
<def><p>normal donkey serum</p></def>
</def-item>
<def-item>
<term>PBS</term>
<def><p>phosphate buffered saline</p></def>
</def-item>
</def-list>
</glossary>
<sec id="s10">
<title>Consent for publication</title>
<p>Human islet transcriptomic data used in this project are all published datasets and the donors are deidentified. Human pancreatic tissue sections were obtained from NDRI and were deidentified. Studies on deidentified human tissue or publicly available human transcriptomics datasets do not constitute human research as defined in 45 CFR 46.102(f).</p>
</sec>
<sec id="s11">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="s12">
<title>Funding</title>
<p>This work was supported by internal funds at the Indiana Biosciences Research Institute (M.A.K. and T.S.J.), AnalytixIN (T.S.J.), Indiana University Precision Health Initiative (T.S.J), 1R01GM148970 (T.S.J), 1R21CA264339 (T.S.J).’</p>
</sec>
<sec id="s13">
<title>Authors’ contributions</title>
<p>G.R., R.S., O.L., S.R., S.D.M., A.M.M., T.S.J., and M.A.K. performed data analyses. G.R. and D.R. performed experiments. M.A.K. and T.S.J. conceived and initiated this project. M.A.K. and T.S.J. supervised the project. A.M.M. provided processed data files. G.R., T.S.J. and M.A.K. wrote the manuscript. All authors read and approved the manuscript.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr. Mark Huising for helpful conversations and providing access to processed data. Thank you to Dr. Andrew Templin for helpful conversations and critical review of the manuscript. Thank you to Dr. Anthony Piron at Université Libre de Bruxelles for assistance with metadata mapping for GSE159984. This work was supported by the Histology Core of the Indiana Center for Musculoskeletal Health at IU School of Medicine and the Bone and Body Composition Core of the Indiana Clinical Translational Sciences Institute (CTSI). A specific thanks to Drew Brown in the Histology Lab Service Core for assisting with pancreas sectioning.</p>
</ack>
<sec id="s14">
<title>Supplemental Information</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Figure S1.</label>
<caption><title>Islet Gene View results of DEGs found in both Marselli et al. and Asplund et al.</title>
<p><italic>FFAR4</italic> (<bold>A</bold>), <italic>UCN5D</italic> (<bold>B</bold>), <italic>SFRP4</italic> (<bold>C</bold>), and <italic>PODN</italic> (<bold>D</bold>) were each significantly regulated in T2D vs. non-T2D human islet RNA-seq data in Marselli et al. and Asplund et al. Plots shown were generated using Islet Gene View browser (<ext-link ext-link-type="uri" xlink:href="https://mae.crc.med.lu.se/IsletGeneView/">https://mae.crc.med.lu.se/IsletGeneView/</ext-link>). <italic>FFAR4</italic> and <italic>UCN5D</italic> were both down-regulated in T2D and <italic>SFRP4</italic> and <italic>PODN</italic> were both up-regulated.</p></caption>
<graphic xlink:href="576260v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Figure S2.</label>
<caption><title>Human islet single cell RNA-seq clusters and diabetes marker genes for all cells and β-cells.</title><p><bold>A</bold>) Seurat clustering of merged human islet scRNA-seq data. <bold>B)</bold> Study identifiers overlaid on single cell plot. <bold>C)</bold> Differential gene expression analysis comparing all cells from T2D donors vs. non-diabetic (ND) donors. <bold>D)</bold> β-cells reclustered and labeled based on donor T2D status. <bold>E)</bold> Differential expression analysis of β-cells from T2D vs. ND donors.</p></caption>
<graphic xlink:href="576260v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Figure S3.</label>
<caption><title>Thresholding analysis for β<sup>T2D-DEGAS</sup> scores and differential gene expression analysis and plots.</title><p><bold>A</bold>) Quantile thresholding and volcano plot comparing the upper 20% of β<sup>T2D-DEGAS</sup> scores to the lower 80%. <bold>B)</bold> Median thresholding and volcano plot comparing the upper 50% vs lower 50% of β<sup>T2D-DEGAS</sup> scoring cells. <bold>C)</bold> Gene expression overlays on β-cells of selected genes that drive enrichment of GO terms and GSEA categories. <bold>D)</bold> GSEA results for high βT2D-DEGAS scoring cells. <bold>E)</bold> GSEA results of low-scoring β<sup>T2D-DEGAS</sup> scoring cells.</p></caption>
<graphic xlink:href="576260v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Figure S4.</label>
<caption><p>Score overlay on all islet cells for β<sup>lean-DEGAS</sup> <bold>(A)</bold> and β<sup>overweight-DEGAS</sup> <bold>(B). C,D)</bold> Similar score overlays are also shown for β-cells alone. <bold>E)</bold> Median thresholding of β<sup>obese-DEGAS</sup> score. <bold>F)</bold> Differential expression analysis for high vs low β<sup>obese-DEGAS</sup> scores based on median threshold. <bold>G)</bold> Subsetting highest-scoring cells based on β<sup>obese-DEGAS</sup> score. <bold>H)</bold> Gene expression overlays on β-cell UMAP. <bold>I)</bold> GSEA results for ND-β<sup>obese-DEGAS</sup> cells. <bold>J)</bold> GSEA results for T2D-β<sup>obese-DEGAS</sup> cells.</p></caption>
<graphic xlink:href="576260v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Figure S5.</label>
<caption><title>Overlap of RePACT trajectory genes with genes identified by DEGAS in human islet scRNA-seq data.</title>
<p>Genes from βT2D-DEGAS (<bold>A</bold>), or ND-β<sup>obese-DEGAS</sup> and T2D-β<sup>obese-DEGAS</sup> (<bold>B</bold>) that had adjusted p-values &lt; 0.05 and |log<sub>2</sub>fold-changed| &gt; 0.58 were selected for comparison to Fang et al. <bold>Table S4</bold> T2D and obesity trajectory genes, respectively.</p></caption>
<graphic xlink:href="576260v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s15">
<title>Additional Files</title>
<p><bold>Table S1. List of bulk and single cell transcriptomic datasets.</bold></p>
<p><bold>Table S2. Bulk RNA-seq metadata, analysis, and comparisons to publicly-available datasets.</bold></p>
<p><bold>Table S3. Differential gene expression in DEGAS-identified β-cell subpopulations.</bold></p>
<p><bold>Table S4. Pathway analysis results.</bold></p>
<p><bold>Table S5. FFPE human pancreas metadata.</bold></p>
<p><bold>Table S6. Antibodies.</bold></p>
<p><bold>Table S7. Comparison of DEGAS T2D and obesity genes to Fang et al. RePACT trajectory genes.</bold></p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Baron</surname> <given-names>M</given-names></string-name>, <string-name><surname>Veres</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wolock</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Faust</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Gaujoux</surname> <given-names>R</given-names></string-name>, <string-name><surname>Vetere</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter-and Intra-cell Population Structure</article-title>. <source>Cell Syst</source>. <year>2016</year>;<volume>3</volume>(<issue>4</issue>):<fpage>346</fpage>–<lpage>60</lpage> e4. doi: <pub-id pub-id-type="doi">10.1016/j.cels.2016.08.011</pub-id>. PMID: <pub-id pub-id-type="pmid">27667365</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Klughammer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Farlik</surname> <given-names>M</given-names></string-name>, <string-name><surname>Penz</surname> <given-names>T</given-names></string-name>, <string-name><surname>Spittler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Barbieux</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types</article-title>. <source>EMBO Rep</source>. <year>2016</year>;<volume>17</volume>(<issue>2</issue>):<fpage>178</fpage>–<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.15252/embr.201540946</pub-id>. PMID: <pub-id pub-id-type="pmid">26691212</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4784001</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Schug</surname> <given-names>J</given-names></string-name>, <string-name><surname>Won</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Naji</surname> <given-names>A</given-names></string-name>, <string-name><surname>Avrahami</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Single-Cell Transcriptomics of the Human Endocrine Pancreas</article-title>. <source>Diabetes</source>. <year>2016</year>;<volume>65</volume>(<issue>10</issue>):<fpage>3028</fpage>–<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.2337/db16-0405</pub-id>. PMID: <pub-id pub-id-type="pmid">27364731</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5033269</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Lawlor</surname> <given-names>N</given-names></string-name>, <string-name><surname>George</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bolisetty</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kursawe</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sivakamasundari</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal> <article-title>Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes</article-title>. <source>Genome Res</source>. <year>2017</year>;<volume>27</volume>(<issue>2</issue>):<fpage>208</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gr.212720.116</pub-id>. PMID: <pub-id pub-id-type="pmid">27864352</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5287227</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Fang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Weng</surname> <given-names>C</given-names></string-name>, <string-name><surname>Li</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tao</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mai</surname> <given-names>W</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>Single-Cell Heterogeneity Analysis and CRISPR Screen Identify Key beta-Cell-Specific Disease Genes</article-title>. <source>Cell Rep</source>. <year>2019</year>;<volume>26</volume>(<issue>11</issue>):<fpage>3132</fpage>–<lpage>44</lpage> e7. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.043</pub-id>. PMID: <pub-id pub-id-type="pmid">30865899</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6573026</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Tritschler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Thomas</surname> <given-names>M</given-names></string-name>, <string-name><surname>Böttcher</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ludwig</surname> <given-names>B</given-names></string-name>, <string-name><surname>Schmid</surname> <given-names>J</given-names></string-name>, <string-name><surname>Schubert</surname> <given-names>U</given-names></string-name>, <etal>et al.</etal> <article-title>A transcriptional cross species map of pancreatic islet cells</article-title>. <source>Molecular Metabolism</source>. <year>2022</year>. doi: <pub-id pub-id-type="doi">10.1016/j.molmet.2022.101595</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Segerstolpe</surname> <given-names>A</given-names></string-name>, <string-name><surname>Palasantza</surname> <given-names>A</given-names></string-name>, <string-name><surname>Eliasson</surname> <given-names>P</given-names></string-name>, <string-name><surname>Andersson</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Andreasson</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes</article-title>. <source>Cell Metab</source>. <year>2016</year>;<volume>24</volume>(<issue>4</issue>):<fpage>593</fpage>–<lpage>607</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.020</pub-id>. PMID: <pub-id pub-id-type="pmid">27667667</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5069352</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Mawla</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Huising</surname> <given-names>MO</given-names></string-name>. <article-title>Navigating the Depths and Avoiding the Shallows of Pancreatic Islet Cell Transcriptomes</article-title>. <source>Diabetes</source>. <year>2019</year>;<volume>68</volume>(<issue>7</issue>):<fpage>1380</fpage>–<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.2337/dbi18-0019</pub-id>. PMID: <pub-id pub-id-type="pmid">31221802</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6609986</pub-id>.</mixed-citation></ref>
 <ref id="c9"><label>9.</label><mixed-citation publication-type="other"><string-name><surname>Elgamal</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Kudtarkar</surname> <given-names>P</given-names></string-name>, <string-name><surname>Melton</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Mummey</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Benaglio</surname> <given-names>P</given-names></string-name>, <string-name><surname>Okino</surname> <given-names>ML</given-names></string-name>, <etal>et al.</etal> <article-title>An integrated map of cell type-specific gene expression in pancreatic islets</article-title>. <source>bioRxiv</source>. 2023. doi: <pub-id pub-id-type="doi">10.1101/2023.02.03.526994</pub-id>. PMID: <pub-id pub-id-type="pmid">36778506</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9915747</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Fabbrini</surname> <given-names>E</given-names></string-name>, <string-name><surname>Yoshino</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yoshino</surname> <given-names>M</given-names></string-name>, <string-name><surname>Magkos</surname> <given-names>F</given-names></string-name>, <string-name><surname>Tiemann Luecking</surname> <given-names>C</given-names></string-name>, <string-name><surname>Samovski</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Metabolically normal obese people are protected from adverse effects following weight gain</article-title>. <source>J Clin Invest</source>. <year>2015</year>;<volume>125</volume>(<issue>2</issue>):<fpage>787</fpage>–<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI78425</pub-id>. PMID: <pub-id pub-id-type="pmid">25555214</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4319438</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Voight</surname> <given-names>BF</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Steinthorsdottir</surname> <given-names>V</given-names></string-name>, <string-name><surname>Morris</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Dina</surname> <given-names>C</given-names></string-name>, <string-name><surname>Welch</surname> <given-names>RP</given-names></string-name>, <etal>et al.</etal> <article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis</article-title>. <source>Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>7</issue>):<fpage>579</fpage>–<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng.609</pub-id>. PMID: <pub-id pub-id-type="pmid">20581827</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC3080658</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Saxena</surname> <given-names>R</given-names></string-name>, <string-name><surname>Voight</surname> <given-names>BF</given-names></string-name>, <string-name><surname>Lyssenko</surname> <given-names>V</given-names></string-name>, <string-name><surname>Burtt</surname> <given-names>NP</given-names></string-name>, <string-name><surname>de Bakker</surname> <given-names>PI</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</article-title>. <source>Science</source>. <year>2007</year>;<volume>316</volume>(5829):<fpage>1331</fpage>-p. doi: <pub-id pub-id-type="doi">10.1126/science.1142358</pub-id>. PMID: <pub-id pub-id-type="pmid">17463246</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Scott</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Mohlke</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Bonnycastle</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Willer</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Duren</surname> <given-names>WL</given-names></string-name>, <etal>et al.</etal> <article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</article-title>. <source>Science</source>. <year>2007</year>;<volume>316</volume>(5829):<fpage>1341</fpage>–<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1142382</pub-id>. PMID: <pub-id pub-id-type="pmid">17463248</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC3214617</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Rottner</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Ye</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Navarro-Guerrero</surname> <given-names>E</given-names></string-name>, <string-name><surname>Rajesh</surname> <given-names>V</given-names></string-name>, <string-name><surname>Pollner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bevacqua</surname> <given-names>RJ</given-names></string-name>, <etal>et al.</etal> <article-title>A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk</article-title>. <source>Nat Genet</source>. <year>2023</year>;<volume>55</volume>(<issue>1</issue>):<fpage>54</fpage>–<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-022-01261-2</pub-id>. PMID: <pub-id pub-id-type="pmid">36543916</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9839450</pub-id> of AstraZeneca, S.K.T. is now an employee of Vertex Pharmaceuticals and A.W-A. is now an employee of Genomics plc. D.E. and E.N-G are now also affiliated with XCellomics. All experimental work by A.K.R., S.K.T. and A.W-A. was carried out under employment at the University of Oxford. A.K.R. holds stocks in Astra Zeneca. A.L.G.’s spouse holds stock options in Roche. The other authors declare no competing interests.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>H</given-names></string-name>, <string-name><surname>Westerman</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>K</given-names></string-name>, <string-name><surname>Chiou</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cole</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Majarian</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease</article-title>. <source>Diabetologia</source>. <year>2022</year>. doi: <pub-id pub-id-type="doi">10.1007/s00125-022-05848-6</pub-id>. PMID: <pub-id pub-id-type="pmid">36538063</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Marselli</surname> <given-names>L</given-names></string-name>, <string-name><surname>Piron</surname> <given-names>A</given-names></string-name>, <string-name><surname>Suleiman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Colli</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Yi</surname> <given-names>X</given-names></string-name>, <string-name><surname>Khamis</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Persistent or Transient Human beta Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes</article-title>. <source>Cell Rep</source>. <year>2020</year>;<volume>33</volume>(<issue>9</issue>):<fpage>108466</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108466</pub-id>. PMID: <pub-id pub-id-type="pmid">33264613</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Asplund</surname> <given-names>O</given-names></string-name>, <string-name><surname>Storm</surname> <given-names>P</given-names></string-name>, <string-name><surname>Chandra</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hatem</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ottosson-Laakso</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mansour-Aly</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Islet Gene View-a tool to facilitate islet research</article-title>. <source>Life Sci Alliance</source>. <year>2022</year>;<volume>5</volume>(<issue>12</issue>). doi: <pub-id pub-id-type="doi">10.26508/lsa.202201376</pub-id>. PMID: <pub-id pub-id-type="pmid">35948367</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Morales</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pujar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Loveland</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Astashyn</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bennett</surname> <given-names>R</given-names></string-name>, <string-name><surname>Berry</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>A joint NCBI and EMBL-EBI transcript set for clinical genomics and research</article-title>. <source>Nature</source>. <year>2022</year>;<volume>604</volume>(<issue>7905</issue>):<fpage>310</fpage>–<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-022-04558-8</pub-id>. PMID: <pub-id pub-id-type="pmid">35388217</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9007741</pub-id> P.F. is a member of the scientific advisory boards of Fabric Genomics, Inc., and Eagle Genomics, Ltd. All other authors declare no competing interests.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Blondel</surname> <given-names>VD</given-names></string-name>, <string-name><surname>Guillaume</surname> <given-names>J-L</given-names></string-name>, <string-name><surname>Lambiotte</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lefebvre</surname> <given-names>E</given-names></string-name>. <article-title>Fast unfolding of communities in large networks</article-title>. <source>Journal of statistical mechanics: theory and experiment</source>. <year>2008</year>;<volume>2008</volume>(<issue>10</issue>):P<fpage>10008</fpage>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Kalwat</surname> <given-names>MA</given-names></string-name>. <article-title>Islet DEGAS v1</article-title>. <source>Mendeley Data</source>. <year>2024</year>. doi: <pub-id pub-id-type="doi">10.17632/3sdxv5tzbd.1</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>YC</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Verchere</surname> <given-names>CB</given-names></string-name>. <article-title>Islet prohormone processing in health and disease</article-title>. <source>Diabetes Obes Metab</source>. <year>2018</year>;<volume>20</volume> <issue>Suppl 2</issue>:<fpage>64</fpage>–<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1111/dom.13401</pub-id>. PMID: <pub-id pub-id-type="pmid">30230179</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Folli</surname> <given-names>F</given-names></string-name>, <string-name><surname>La Rosa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Finzi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Davalli</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Galli</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dick</surname> <given-names>EJ</given-names>, <suffix>Jr.</suffix></string-name>, <etal>et al.</etal> <article-title>Pancreatic islet of Langerhans’ cytoarchitecture and ultrastructure in normal glucose tolerance and in type 2 diabetes mellitus</article-title>. <source>Diabetes Obes Metab</source>. <year>2018</year>;<volume>20</volume> <issue>Suppl 2</issue>:<fpage>137</fpage>–<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1111/dom.13380</pub-id>. PMID: <pub-id pub-id-type="pmid">30230173</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Lorenzo</surname> <given-names>PI</given-names></string-name>, <string-name><surname>Fuente-Martin</surname> <given-names>E</given-names></string-name>, <string-name><surname>Brun</surname> <given-names>T</given-names></string-name>, <string-name><surname>Cobo-Vuilleumier</surname> <given-names>N</given-names></string-name>, <string-name><surname>Jimenez-Moreno CM</surname>, <given-names>I GHG</given-names></string-name>, <etal>et al.</etal> <article-title>PAX4 Defines an Expandable beta-Cell Subpopulation in the Adult Pancreatic Islet</article-title>. <source>Sci Rep</source>. <year>2015</year>;<volume>5</volume>:<issue>15672</issue>. doi: <pub-id pub-id-type="doi">10.1038/srep15672</pub-id>. PMID: <pub-id pub-id-type="pmid">26503027</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4622080</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Collombat</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mansouri</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hecksher-Sorensen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Serup</surname> <given-names>P</given-names></string-name>, <string-name><surname>Krull</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gradwohl</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Opposing actions of Arx and Pax4 in endocrine pancreas development</article-title>. <source>Genes Dev</source>. <year>2003</year>;<volume>17</volume>(<issue>20</issue>):<fpage>2591</fpage>–<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.269003</pub-id>. PMID: <pub-id pub-id-type="pmid">14561778</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC218152</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Dupuis</surname> <given-names>J</given-names></string-name>, <string-name><surname>Langenberg</surname> <given-names>C</given-names></string-name>, <string-name><surname>Prokopenko</surname> <given-names>I</given-names></string-name>, <string-name><surname>Saxena</surname> <given-names>R</given-names></string-name>, <string-name><surname>Soranzo</surname> <given-names>N</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>AU</given-names></string-name>, <etal>et al.</etal> <article-title>New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk</article-title>. <source>Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng.520</pub-id>. PMID: <pub-id pub-id-type="pmid">20081858</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC3018764</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Wu</surname> <given-names>CT</given-names></string-name>, <string-name><surname>Hilgendorf</surname> <given-names>KI</given-names></string-name>, <string-name><surname>Bevacqua</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Hang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Demeter</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>SK</given-names></string-name>, <etal>et al.</etal> <article-title>Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion</article-title>. <source>Genes Dev</source>. <year>2021</year>. doi: <pub-id pub-id-type="doi">10.1101/gad.348261.121</pub-id>. PMID: <pub-id pub-id-type="pmid">34385262</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Docherty</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Riemondy</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Castro-Gutierrez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Dwulet</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Shilleh</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>MS</given-names></string-name>, <etal>et al.</etal> <article-title>ENTPD3 Marks Mature Stem Cell-Derived beta-Cells Formed by Self-Aggregation In Vitro</article-title>. <source>Diabetes</source>. <year>2021</year>;<volume>70</volume>(<issue>11</issue>):<fpage>2554</fpage>–<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.2337/db20-0873</pub-id>. PMID: <pub-id pub-id-type="pmid">34380694</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC8564403</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Syed</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Kauffman</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Beavers</surname> <given-names>LS</given-names></string-name>, <string-name><surname>Alston</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Farb</surname> <given-names>TB</given-names></string-name>, <string-name><surname>Ficorilli</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Ectonucleotidase NTPDase3 is abundant in pancreatic beta-cells and regulates glucose-induced insulin secretion</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2013</year>;<volume>305</volume>(<issue>10</issue>):<fpage>E1319</fpage>–<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpendo.00328.2013</pub-id>. PMID: <pub-id pub-id-type="pmid">24085034</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Costanzo</surname> <given-names>MC</given-names></string-name>, <string-name><surname>von Grotthuss</surname> <given-names>M</given-names></string-name>, <string-name><surname>Massung</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Caulkins</surname> <given-names>L</given-names></string-name>, <string-name><surname>Koesterer</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits</article-title>. <source>Cell Metab</source>. <year>2023</year>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2023.03.001</pub-id>. PMID: <pub-id pub-id-type="pmid">36963395</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Forgetta</surname> <given-names>V</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Vulpescu</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Hogan</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Morris</surname> <given-names>JA</given-names></string-name>, <etal>et al.</etal> <article-title>An effector index to predict target genes at GWAS loci</article-title>. <source>Hum Genet</source>. <year>2022</year>;<volume>141</volume>(<issue>8</issue>):<fpage>1431</fpage>–<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00439-022-02434-z</pub-id>. PMID: <pub-id pub-id-type="pmid">35147782</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease</article-title>. <source>Genome Med</source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>):<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13073-022-01012-2</pub-id>. PMID: <pub-id pub-id-type="pmid">35105355</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC8808996</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Weir</surname> <given-names>GC</given-names></string-name>, <string-name><surname>Gaglia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bonner-Weir</surname> <given-names>S</given-names></string-name>. <article-title>Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes</article-title>. <source>The Lancet Diabetes &amp; Endocrinology</source>. <year>2020</year>;<volume>8</volume>(<issue>3</issue>):<fpage>249</fpage>–<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s2213-8587(20)30022-x</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Stampone</surname> <given-names>E</given-names></string-name>, <string-name><surname>Caldarelli</surname> <given-names>I</given-names></string-name>, <string-name><surname>Zullo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bencivenga</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mancini</surname> <given-names>FP</given-names></string-name>, <string-name><surname>Della Ragione</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases</article-title>. <source>Int J Mol Sci</source>. <year>2018</year>;<volume>19</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.3390/ijms19041055</pub-id>. PMID: <pub-id pub-id-type="pmid">29614816</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5979523</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Ou</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moss</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>AW</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>SC</given-names></string-name>, <etal>et al.</etal> <article-title>Targeted demethylation at the CDKN1C/p57 locus induces human beta cell replication</article-title>. <source>J Clin Invest</source>. <year>2019</year>;<volume>129</volume>(<issue>1</issue>):<fpage>209</fpage>–<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI99170</pub-id>. PMID: <pub-id pub-id-type="pmid">30352048</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6307972</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Wallace</surname> <given-names>C</given-names></string-name>, <string-name><surname>Smyth</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Maisuria-Armer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Walker</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Todd</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Clayton</surname> <given-names>DG</given-names></string-name>. <article-title>The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes</article-title>. <source>Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>1</issue>):<fpage>68</fpage>–<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng.493</pub-id>. PMID: <pub-id pub-id-type="pmid">19966805</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC2820243</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Kameswaran</surname> <given-names>V</given-names></string-name>, <string-name><surname>Golson</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Ramos-Rodriguez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ou</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>The Dysregulation of the DLK1-MEG3 Locus in Islets From Patients With Type 2 Diabetes Is Mimicked by Targeted Epimutation of Its Promoter With TALE-DNMT Constructs</article-title>. <source>Diabetes</source>. <year>2018</year>;<volume>67</volume>(<issue>9</issue>):<fpage>1807</fpage>–<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.2337/db17-0682</pub-id>. PMID: <pub-id pub-id-type="pmid">30084829</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6110314</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Park</surname> <given-names>J</given-names></string-name>, <string-name><surname>Susztak</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>. <article-title>Bulk tissue cell type deconvolution with multi-subject single-cell expression reference</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>380</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-08023-x</pub-id>. PMID: <pub-id pub-id-type="pmid">30670690</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6342984</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Newman</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Steen</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Gentles</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Chaudhuri</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Scherer</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry</article-title>. <source>Nat Biotechnol</source>. <year>2019</year>;<volume>37</volume>(<issue>7</issue>):<fpage>773</fpage>–<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41587-019-0114-2</pub-id>. PMID: <pub-id pub-id-type="pmid">31061481</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6610714</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Tsoucas</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>GC</given-names></string-name>. <article-title>Accurate estimation of cell-type composition from gene expression data</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>2975</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-10802-z</pub-id>. PMID: <pub-id pub-id-type="pmid">31278265</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6611906</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Herman JS</surname>, <given-names>Sagar</given-names></string-name>, <string-name><surname>Grun</surname> <given-names>D</given-names></string-name>. <article-title>FateID infers cell fate bias in multipotent progenitors from single-cell RNA-seq data</article-title>. <source>Nat Methods</source>. <year>2018</year>;<volume>15</volume>(<issue>5</issue>):<fpage>379</fpage>–<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.4662</pub-id>. PMID: <pub-id pub-id-type="pmid">29630061</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>X</given-names></string-name>. <article-title>scAB detects multiresolution cell states with clinical significance by integrating single-cell genomics and bulk sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2022</year>;<volume>50</volume>(<issue>21</issue>):<fpage>12112</fpage>–<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1109</pub-id>. PMID: <pub-id pub-id-type="pmid">36440766</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9757078</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname> <given-names>D</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>X</given-names></string-name>, <string-name><surname>Moran</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>LY</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>DZ</given-names></string-name>, <string-name><surname>Schedin</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data</article-title>. <source>Nat Biotechnol</source>. <year>2022</year>;<volume>40</volume>(<issue>4</issue>):<fpage>527</fpage>–<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41587-021-01091-3</pub-id>. PMID: <pub-id pub-id-type="pmid">34764492</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9010342</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>QE</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>6494</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-34277-7</pub-id>. PMID: <pub-id pub-id-type="pmid">36310235</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9618578</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Broadaway</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Yin</surname> <given-names>X</given-names></string-name>, <string-name><surname>Williamson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Parsons</surname> <given-names>VA</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>EP</given-names></string-name>, <string-name><surname>Moxley</surname> <given-names>AH</given-names></string-name>, <etal>et al.</etal> <article-title>Loci for insulin processing and secretion provide insight into type 2 diabetes risk</article-title>. <source>Am J Hum Genet</source>. <year>2023</year>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2023.01.002</pub-id>. PMID: <pub-id pub-id-type="pmid">36693378</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Bevacqua</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Lam</surname> <given-names>JY</given-names></string-name>, <string-name><surname>Peiris</surname> <given-names>H</given-names></string-name>, <string-name><surname>Whitener</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gu</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>SIX2 and SIX3 coordinately regulate functional maturity and fate of human pancreatic beta cells</article-title>. <source>Genes Dev</source>. <year>2021</year>;<volume>35</volume>(<issue>3-4</issue>):<fpage>234</fpage>–<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.342378.120</pub-id>. PMID: <pub-id pub-id-type="pmid">33446570</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC7849364</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Weng</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ke</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Single cell multiomic analysis reveals diabetes-associated beta-cell heterogeneity driven by HNF1A</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>5400</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-41228-3</pub-id>. PMID: <pub-id pub-id-type="pmid">37669939</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Tsuyama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yoshizawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Matsuoka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yamagata</surname> <given-names>K</given-names></string-name>. <article-title>Hypoxia causes pancreatic beta-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40</article-title>. <source>EMBO Rep</source>. <year>2023</year>:<fpage>e56227</fpage>. doi: <pub-id pub-id-type="doi">10.15252/embr.202256227</pub-id>. PMID: <pub-id pub-id-type="pmid">37341148</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Avrahami</surname> <given-names>D</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jiao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Naji</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Targeting the cell cycle inhibitor p57Kip2 promotes adult human beta cell replication</article-title>. <source>J Clin Invest</source>. <year>2014</year>;<volume>124</volume>(<issue>2</issue>):<fpage>670</fpage>–<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI69519</pub-id>. PMID: <pub-id pub-id-type="pmid">24430183</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC3904605</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Kerns</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Guevara-Aguirre</surname> <given-names>J</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>S</given-names></string-name>, <string-name><surname>Geng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guevara</surname> <given-names>C</given-names></string-name>, <string-name><surname>Guevara-Aguirre</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2014</year>;<volume>99</volume>(<issue>10</issue>):<fpage>E2117</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jc.2014-1949</pub-id>. PMID: <pub-id pub-id-type="pmid">25057881</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4184067</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Brioude</surname> <given-names>F</given-names></string-name>, <string-name><surname>Netchine</surname> <given-names>I</given-names></string-name>, <string-name><surname>Praz</surname> <given-names>F</given-names></string-name>, <string-name><surname>Le Jule</surname> <given-names>M</given-names></string-name>, <string-name><surname>Calmel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lacombe</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization</article-title>. <source>Hum Mutat</source>. <year>2015</year>;<volume>36</volume>(<issue>9</issue>):<fpage>894</fpage>–<lpage>902</lpage>. doi: <pub-id pub-id-type="doi">10.1002/humu.22824</pub-id>. PMID: <pub-id pub-id-type="pmid">26077438</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Augsornworawat</surname> <given-names>P</given-names></string-name>, <string-name><surname>Maxwell</surname> <given-names>KG</given-names></string-name>, <string-name><surname>Velazco-Cruz</surname> <given-names>L</given-names></string-name>, <string-name><surname>Millman</surname> <given-names>JR</given-names></string-name>. <article-title>Single-Cell Transcriptome Profiling Reveals beta Cell Maturation in Stem Cell-Derived Islets after Transplantation</article-title>. <source>Cell Rep</source>. <year>2020</year>;<volume>32</volume>(<issue>8</issue>):<fpage>108067</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108067</pub-id>. PMID: <pub-id pub-id-type="pmid">32846125</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Bulfoni</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bouyioukos</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zakaria</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nigon</surname> <given-names>F</given-names></string-name>, <string-name><surname>Rapone</surname> <given-names>R</given-names></string-name>, <string-name><surname>Del Maestro</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Glucose controls co-translation of structurally related mRNAs via the mTOR and eIF2 pathways in human pancreatic beta cells</article-title>. <source>Front Endocrinol (Lausanne</source>). <year>2022</year>;<volume>13</volume>:<issue>949097</issue>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2022.949097</pub-id>. PMID: <pub-id pub-id-type="pmid">35992129</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9388909</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Stierman</surname> <given-names>B</given-names></string-name>, <string-name><surname>Afful</surname> <given-names>J</given-names></string-name>, <string-name><surname>Carroll</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>T-C</given-names></string-name>, <string-name><surname>Davy</surname> <given-names>O</given-names></string-name>, <string-name><surname>Steven</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> National Health and Nutrition Examination Survey <year>2017</year><article-title>–March 2020 prepandemic data files—Development of files and prevalence estimates for selected health outcomes</article-title>. <source>National Health Statistics Reports. National Center for Health Statistics</source>. <volume>2021</volume>;no. <fpage>158</fpage>. doi: <pub-id pub-id-type="doi">10.15620/cdc:106273</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="report"><collab>Centers for Disease Control and Prevention</collab>. <article-title>National Diabetes Statistics Report website</article-title>. [cited 12/26/2022]; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/diabetes/data/statistics-report/index.html">https://www.cdc.gov/diabetes/data/statistics-report/index.html</ext-link>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Smith</surname> <given-names>GI</given-names></string-name>, <string-name><surname>Mittendorfer</surname> <given-names>B</given-names></string-name>, <string-name><surname>Klein</surname> <given-names>S</given-names></string-name>. <article-title>Metabolically healthy obesity: facts and fantasies</article-title>. <source>J Clin Invest</source>. <year>2019</year>;<volume>129</volume>(<issue>10</issue>):<fpage>3978</fpage>–<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI129186</pub-id>. PMID: <pub-id pub-id-type="pmid">31524630</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6763224</pub-id> funding from Merck Sharp &amp; Dohme Corp. and Janssen Pharmaceuticals, and has served as a consultant for Pfizer, Novo Nordisk, and Merck Sharp &amp; Dohme Corp.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Dominguez-Gutierrez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Xin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gromada</surname> <given-names>J</given-names></string-name>. <article-title>Heterogeneity of human pancreatic beta-cells</article-title>. <source>Mol Metab</source>. <year>2019</year>;<volume>27S</volume>(<issue>Suppl</issue>):<fpage>S7</fpage>–<lpage>S14</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molmet.2019.06.015</pub-id>. PMID: <pub-id pub-id-type="pmid">31500834</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6768494</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Muraro</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Dharmadhikari</surname> <given-names>G</given-names></string-name>, <string-name><surname>Grun</surname> <given-names>D</given-names></string-name>, <string-name><surname>Groen</surname> <given-names>N</given-names></string-name>, <string-name><surname>Dielen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jansen</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>A Single-Cell Transcriptome Atlas of the Human Pancreas</article-title>. <source>Cell Syst</source>. <year>2016</year>;<volume>3</volume>(<issue>4</issue>):<fpage>385</fpage>–<lpage>94</lpage> e3. doi: <pub-id pub-id-type="doi">10.1016/j.cels.2016.09.002</pub-id>. PMID: <pub-id pub-id-type="pmid">27693023</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5092539</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Bu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Geuze</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Strous</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>AL</given-names></string-name>. <article-title>39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein</article-title>. <source>EMBO J</source>. <year>1995</year>;<volume>14</volume>(<issue>10</issue>):<fpage>2269</fpage>–<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb07221.x</pub-id>. PMID: <pub-id pub-id-type="pmid">7774585</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC398334</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Uhlen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Karlsson</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Hober</surname> <given-names>A</given-names></string-name>, <string-name><surname>Svensson</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Scheffel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kotol</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>The human secretome</article-title>. <source>Sci Signal</source>. <year>2019</year>;<volume>12</volume>(<issue>609</issue>). doi: <pub-id pub-id-type="doi">10.1126/scisignal.aaz0274</pub-id>. PMID: <pub-id pub-id-type="pmid">31772123</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Atanes</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ruz-Maldonado</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hawkes</surname> <given-names>R</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>M</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>GC</given-names></string-name>, <etal>et al.</etal> <article-title>Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets</article-title>. <source>Cell Mol Life Sci</source>. <year>2018</year>;<volume>75</volume>(<issue>16</issue>):<fpage>3039</fpage>–<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-018-2778-z</pub-id>. PMID: <pub-id pub-id-type="pmid">29455414</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6061145</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Gupta</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Schaid</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Lei</surname> <given-names>X</given-names></string-name>, <string-name><surname>Balamurugan</surname> <given-names>AN</given-names></string-name>, <string-name><surname>Wong</surname> <given-names>GW</given-names></string-name>, <etal>et al.</etal> <article-title>Complement 1q like-3 protein inhibits insulin secretion from pancreatic beta-cells via the cell adhesion G protein-coupled receptor BAI3</article-title>. <source>J Biol Chem</source>. <year>2018</year>. doi: <pub-id pub-id-type="doi">10.1074/jbc.RA118.005403</pub-id>. PMID: <pub-id pub-id-type="pmid">30228187</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Dorrell</surname> <given-names>C</given-names></string-name>, <string-name><surname>Schug</surname> <given-names>J</given-names></string-name>, <string-name><surname>Canaday</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Russ</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Tarlow</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Grompe</surname> <given-names>MT</given-names></string-name>, <etal>et al.</etal> <article-title>Human islets contain four distinct subtypes of beta cells</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<issue>11756</issue>. doi: <pub-id pub-id-type="doi">10.1038/ncomms11756</pub-id>. PMID: <pub-id pub-id-type="pmid">27399229</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4942571</pub-id> (HPi2/HIC1-2B4, HPx1/HIC0-3B3, HPd3/DHIC5-4D9); C.D., P.R.S and M.G. are inventors of these antibodies. This potential conflict of interest has been reviewed and managed by OHSU. The remaining authors declare no competing financial interest.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Bader</surname> <given-names>E</given-names></string-name>, <string-name><surname>Migliorini</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gegg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moruzzi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gerdes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Roscioni</surname> <given-names>SS</given-names></string-name>, <etal>et al.</etal> <article-title>Identification of proliferative and mature beta-cells in the islets of Langerhans</article-title>. <source>Nature</source>. <year>2016</year>;<volume>535</volume>(7612):<fpage>430</fpage>-4. doi: <pub-id pub-id-type="doi">10.1038/nature18624</pub-id>. PMID: <pub-id pub-id-type="pmid">27398620</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>van der Meulen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>OG</given-names></string-name>, <string-name><surname>Vale</surname> <given-names>WW</given-names></string-name>, <string-name><surname>Sander</surname> <given-names>M</given-names></string-name>, <string-name><surname>Huising</surname> <given-names>MO</given-names></string-name>. <article-title>Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>12</issue>):<fpage>e52181</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0052181</pub-id>. PMID: <pub-id pub-id-type="pmid">23251699</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC3522648</pub-id> following conflicts: OGK is an employee of Viacyte, receiving salary and/or stock options. The paper describes or references intellectual property owned by Viacyte. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare that no competing interests exist.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Camunas-Soler</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dai</surname> <given-names>XQ</given-names></string-name>, <string-name><surname>Hang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Bautista</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lyon</surname> <given-names>J</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title>Patch-Seq Links Single-Cell Transcriptomes to Human Islet Dysfunction in Diabetes</article-title>. <source>Cell Metab</source>. <year>2020</year>;<volume>31</volume>(<issue>5</issue>):<fpage>1017</fpage>–<lpage>31</lpage> e4. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2020.04.005</pub-id>. PMID: <pub-id pub-id-type="pmid">32302527</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC7398125</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="other"><string-name><surname>Kravets</surname> <given-names>V</given-names></string-name>, <string-name><surname>Dwulet</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Schleicher</surname> <given-names>WE</given-names></string-name>, <string-name><surname>Hodson</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Davis</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Pyle</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Functional architecture of the pancreatic islets: first responder cells drive the first-phase [Ca2+] response</article-title>. <source>bioRxiv</source>. <year>2021</year>.doi: <pub-id pub-id-type="doi">10.1101/2020.12.22.424082</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Salem</surname> <given-names>V</given-names></string-name>, <string-name><surname>Silva</surname> <given-names>LD</given-names></string-name>, <string-name><surname>Suba</surname> <given-names>K</given-names></string-name>, <string-name><surname>Georgiadou</surname> <given-names>E</given-names></string-name>, <string-name><surname>Neda Mousavy Gharavy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Akhtar</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title>Leader beta-cells coordinate Ca(2+) dynamics across pancreatic islets in vivo</article-title>. <source>Nat Metab.</source> <year>2019</year>;<volume>1</volume>(<issue>6</issue>):<fpage>615</fpage>–<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s42255-019-0075-2</pub-id>. PMID: <pub-id pub-id-type="pmid">32694805</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Johnston</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Haythorne</surname> <given-names>E</given-names></string-name>, <string-name><surname>Pessoa</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Semplici</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ferrer</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose</article-title>. <source>Cell Metab</source>. <year>2016</year>;<volume>24</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>401</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.020</pub-id>. PMID: <pub-id pub-id-type="pmid">27452146</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC5031557</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Weidemann</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Marcheva</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kobayashi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Omura</surname> <given-names>C</given-names></string-name>, <string-name><surname>Newman</surname> <given-names>MV</given-names></string-name>, <string-name><surname>Kobayashi</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>Repression of latent NF-kappaB enhancers by PDX1 regulates beta cell functional heterogeneity</article-title>. <source>Cell Metab</source>. <year>2024</year>;<volume>36</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>102</lpage> e7. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2023.11.018</pub-id>. PMID: <pub-id pub-id-type="pmid">38171340</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Morris</surname> <given-names>SA</given-names></string-name>. <article-title>The evolving concept of cell identity in the single cell era</article-title>. <source>Development</source>. <year>2019</year>;<volume>146</volume>(<issue>12</issue>). doi: <pub-id pub-id-type="doi">10.1242/dev.169748</pub-id>. PMID: <pub-id pub-id-type="pmid">31249002</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><given-names>Cell</given-names> <surname>Systems V</surname></string-name>. <article-title>What Is Your Conceptual Definition of “Cell Type” in the Context of a Mature Organism?</article-title> <source>Cell Syst</source>. <year>2017</year>;<volume>4</volume>(<issue>3</issue>):<fpage>255</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cels.2017.03.006</pub-id>. PMID: <pub-id pub-id-type="pmid">28334573</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Xin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>J</given-names></string-name>, <string-name><surname>Okamoto</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ni</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Adler</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes</article-title>. <source>Cell Metab</source>. <year>2016</year>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.018</pub-id>. PMID: <pub-id pub-id-type="pmid">27667665</pub-id>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Kobayashi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wagatsuma</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ono</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ichikawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yamazaki</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tashiro</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3</article-title>. <source>Genes Cells</source>. <year>2000</year>;<volume>5</volume>(<issue>12</issue>):<fpage>1029</fpage>–<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2443.2000.00390.x</pub-id>. PMID: <pub-id pub-id-type="pmid">11168589</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Han</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> <article-title>Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism</article-title>. <source>Exp Hematol Oncol</source>. <year>2023</year>;<volume>12</volume>(<issue>1</issue>):<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40164-022-00369-9</pub-id>. PMID: <pub-id pub-id-type="pmid">36653853</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC9850540</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Grassi</surname> <given-names>ES</given-names></string-name>, <string-name><surname>Pietras</surname> <given-names>A</given-names></string-name>. <article-title>Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness</article-title>. <source>J Histochem Cytochem</source>. <year>2022</year>;<volume>70</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1369/00221554211048951</pub-id>. PMID: <pub-id pub-id-type="pmid">34606325</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC8721543</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Nueda</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Naranjo</surname> <given-names>AI</given-names></string-name>, <string-name><surname>Baladron</surname> <given-names>V</given-names></string-name>, <string-name><surname>Laborda</surname> <given-names>J</given-names></string-name>. <article-title>The proteins DLK1 and DLK2 modulate NOTCH1-dependent proliferation and oncogenic potential of human SK-MEL-2 melanoma cells</article-title>. <source>Biochim Biophys Acta</source>. <year>2014</year>;<volume>1843</volume>(<issue>11</issue>):<fpage>2674</fpage>–<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.07.015</pub-id>. PMID: <pub-id pub-id-type="pmid">25093684</pub-id>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Abdallah</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Ditzel</surname> <given-names>N</given-names></string-name>, <string-name><surname>Laborda</surname> <given-names>J</given-names></string-name>, <string-name><surname>Karsenty</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kassem</surname> <given-names>M</given-names></string-name>. <article-title>DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop</article-title>. <source>Diabetes</source>. <year>2015</year>;<volume>64</volume>(<issue>9</issue>):<fpage>3069</fpage>–<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.2337/db14-1642</pub-id>. PMID: <pub-id pub-id-type="pmid">25918236</pub-id>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>Z</given-names></string-name>, <string-name><surname>D’Oliveira Albanus</surname> <given-names>R</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Han</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Orchard</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>An integrative single-cell multi-omics profiling of human pancreatic islets identifies T1D associated genes and regulatory signals</article-title>. <source>Res Sq</source>. <year>2023</year>. doi: <pub-id pub-id-type="doi">10.21203/rs.3.rs-3343318/v1</pub-id>. PMID: <pub-id pub-id-type="pmid">37886586</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC10602166</pub-id> of Vesalius Therapeutics. The other authors declare no competing interest.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Korsunsky</surname> <given-names>I</given-names></string-name>, <string-name><surname>Millard</surname> <given-names>N</given-names></string-name>, <string-name><surname>Fan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Slowikowski</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title>. <source>Nat Methods</source>. <year>2019</year>;<volume>16</volume>(<issue>12</issue>):<fpage>1289</fpage>–<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id>. PMID: <pub-id pub-id-type="pmid">31740819</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6884693</pub-id>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Shao</surname> <given-names>W</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Helm</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>BERMUDA: a novel deep transfer learning method for single-cell RNA sequencing batch correction reveals hidden high-resolution cellular subtypes</article-title>. <source>Genome Biol</source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>165</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-019-1764-6</pub-id>. PMID: <pub-id pub-id-type="pmid">31405383</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6691531</pub-id>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Hie</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bryson</surname> <given-names>B</given-names></string-name>, <string-name><surname>Berger</surname> <given-names>B</given-names></string-name>. <article-title>Efficient integration of heterogeneous single-cell transcriptomes using Scanorama</article-title>. <source>Nat Biotechnol</source>. <year>2019</year>;<volume>37</volume>(<issue>6</issue>):<fpage>685</fpage>–<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41587-019-0113-3</pub-id>. PMID: <pub-id pub-id-type="pmid">31061482</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC6551256</pub-id>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Hart</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Kudva</surname> <given-names>YC</given-names></string-name>, <string-name><surname>Yadav</surname> <given-names>D</given-names></string-name>, <string-name><surname>Andersen</surname> <given-names>DK</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Toledo</surname> <given-names>FGS</given-names></string-name>, <etal>et al.</etal> <article-title>A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2023</year>;<volume>108</volume>(<issue>5</issue>):<fpage>e120</fpage>–<lpage>e8</lpage>. doi: <pub-id pub-id-type="doi">10.1210/clinem/dgac670</pub-id>. PMID: <pub-id pub-id-type="pmid">36404274</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC10306084</pub-id>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="other"><string-name><surname>Couetil</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Alomari</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>K</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>TS</given-names></string-name>. <article-title>Diagnostic Evidence Gauge of Spatial Transcriptomics (DEGAS): Using transfer learning to map clinical data to spatial transcriptomics in prostate cancer</article-title>. <source>bioRxiv</source>. <year>2023</year>. doi: <pub-id pub-id-type="doi">10.1101/2023.04.21.537852</pub-id>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Mootha</surname> <given-names>VK</given-names></string-name>, <string-name><surname>Lindgren</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Eriksson</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Subramanian</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sihag</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lehar</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title>. <source>Nat Genet</source>. <year>2003</year>;<volume>34</volume>(<issue>3</issue>):<fpage>267</fpage>–<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng1180</pub-id>. PMID: <pub-id pub-id-type="pmid">12808457</pub-id>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><string-name><surname>Subramanian</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tamayo</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mootha</surname> <given-names>VK</given-names></string-name>, <string-name><surname>Mukherjee</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ebert</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Gillette</surname> <given-names>MA</given-names></string-name>, <etal>et al.</etal> <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>43</issue>):<fpage>15545</fpage>–<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>. PMID: <pub-id pub-id-type="pmid">16199517</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC1239896</pub-id>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Liberzon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Birger</surname> <given-names>C</given-names></string-name>, <string-name><surname>Thorvaldsdottir</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ghandi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mesirov</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Tamayo</surname> <given-names>P</given-names></string-name>. <article-title>The Molecular Signatures Database (MSigDB) hallmark gene set collection</article-title>. <source>Cell Syst</source>. <year>2015</year>;<volume>1</volume>(<issue>6</issue>):<fpage>417</fpage>–<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id>. PMID: <pub-id pub-id-type="pmid">26771021</pub-id>. PMCID: <pub-id pub-id-type="pmcid">PMC4707969</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96713.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sussel</surname>
<given-names>Lori</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Colorado Anschutz Medical Campus</institution>
</institution-wrap>
<city>Aurora</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>This is a <bold>useful</bold> study that used DEGAS, a deep transfer learning tool, to identify distinct pancreatic beta cell subpopulations that could be associated with type 2 diabetes (T2D) and/or obesity status. The data supporting the authors' findings is <bold>solid</bold> and demonstrates that DEGAS will be a helpful tool for analyzing cell-specific transcriptomic phenotypes. This study will be of interest to researchers studying the genetics of T2D.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96713.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this manuscript, Roy et al. used the previously published deep transfer learning tool, DEGAS, to map disease associations onto single-cell RNA-seq data from bulk expression data. The authors performed independent runs of DEGAS using T2D or obesity status and identified distinct β-cell subpopulations. β-cells with high obese-DEGAS scores contained two subpopulations derived largely from either non-diabetic or T2D donors. Finally, immunostaining using human pancreas sections from healthy and T2D donors validated the heterogeneous expression and depletion of DLK1 in T2D islets.</p>
<p>Strengths:</p>
<p>(1) This meta-analysis of previously published scRNA-seq data using a deep transfer learning tool.</p>
<p>(2) Identification of novel beta cell subclusters.</p>
<p>(3) Identified a relatively innovative role of DLK1 in T2D disease progression.</p>
<p>Weaknesses:</p>
<p>(1) There is little overlap of the DE list of bulk RNA-seq analysis in Figure 1D and 1E overlap with the DE list of pseudo-bulk RNA-seq analysis of all cells in Figure S2C.</p>
<p>(2) The biological meaning of &quot;beta cells had the lowest scores compared to other cell types&quot; is not clear.</p>
<p>(3) The figures and supplemental figures were not cited following the sequence, which makes the manuscript very difficult to read. Some supplemental figures, such as Figures S1C-S1D, S2B-S2E, S3A-S3B, were not cited or mentioned in the text.</p>
<p>(4) In Figure 7, the current resolution is too low to determine the localization of DLK1.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96713.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The manuscript by Gitanjali Roy et al. applies deep transfer learning (DEGAS) to assign patient-level disease attributes (metadata) to single cells of T2D and non-diabetic patients, including obese patients. This led to the identification of a singular cluster of T2D-associated β-cells; and two subpopulations of obese- β-cells derived from either non-diabetic or T2D donors. The objective was to identify novel and established genes implicated in T2D and obesity. Their final goal is to validate their findings at the protein level using immunohistochemistry of pancreas tissue from non-diabetic and T2D organ donors.</p>
<p>Strengths:</p>
<p>This paper is well-written, and the findings are relevant for β-cell heterogeneity in T2D and obesity.</p>
<p>Weaknesses:</p>
<p>The validation they provide is not sufficiently strong: no DLK1 immunohistochemistry is shown of obese patient-derived sections. Additional presumptive relevant candidates from this transcriptomic analysis should be screened for, at the protein level.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96713.1.sa3</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Roy</surname>
<given-names>Gitanjali</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9622-0184</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Syed</surname>
<given-names>Rameesha</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lazaro</surname>
<given-names>Olivia</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robertson</surname>
<given-names>Sylvia</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCabe</surname>
<given-names>Sean D.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3401-5334</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>Daniela</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mawla</surname>
<given-names>Alex M.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0907-464X</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Travis S.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4628-2256</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Kalwat</surname>
<given-names>Michael A.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8349-9470</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this manuscript, Roy et al. used the previously published deep transfer learning tool, DEGAS, to map disease associations onto single-cell RNA-seq data from bulk expression data. The authors performed independent runs of DEGAS using T2D or obesity status and identified distinct β-cell subpopulations. β-cells with high obese-DEGAS scores contained two subpopulations derived largely from either non-diabetic or T2D donors. Finally, immunostaining using human pancreas sections from healthy and T2D donors validated the heterogeneous expression and depletion of DLK1 in T2D islets.</p>
<p>Strengths:</p>
<p>(1) This meta-analysis of previously published scRNA-seq data using a deep transfer learning tool.</p>
<p>(2) Identification of novel beta cell subclusters.</p>
<p>(3) Identified a relatively innovative role of DLK1 in T2D disease progression.</p>
</disp-quote>
<p>We thank the reviewer for their constructive critiques and positive feedback. We hope to further apply deep transfer learning tools in future scRNA-seq meta-analyses.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>(1) There is little overlap of the DE list of bulk RNA-seq analysis in Figure 1D and 1E overlap with the DE list of pseudo-bulk RNA-seq analysis of all cells in Figure S2C.</p>
</disp-quote>
<p>We thank the reviewer for this insightful thought and plan to perform additional analyses and comparisons to address this comment.</p>
<disp-quote content-type="editor-comment">
<p>(2) The biological meaning of &quot;beta cells had the lowest scores compared to other cell types&quot; is not clear.</p>
</disp-quote>
<p>We agree with the reviewer and will amend this statement to clarify in the revised manuscript. In summary, the relatively lower T2D-DEGAS scores for beta cells overall compared to all other cell types (alpha cells, acinar cells, etc) reflects the fact that in T2D, beta cell-specific genes can be downregulated. This is also possibly due to beta cell loss in T2D and would be reflected in bulk islet RNAseq data. This affects the DEGAS model which is reflected in the scores of all cells in the scRNA-seq data (Fig 3A). For this reason, subsetting the beta cells and replotting them on their own (Fig 4B) is an important step to identify relative differences in DEGAS scores between different subsets of beta cells.</p>
<disp-quote content-type="editor-comment">
<p>(3) The figures and supplemental figures were not cited following the sequence, which makes the manuscript very difficult to read. Some supplemental figures, such as Figures S1C-S1D, S2B-S2E, S3A-S3B, were not cited or mentioned in the text.</p>
</disp-quote>
<p>We apologize and thank the reviewer for pointing out these errors. All of the annotated errors will be amended in the revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(4) In Figure 7, the current resolution is too low to determine the localization of DLK1.</p>
</disp-quote>
<p>We will include the original highest-resolution confocal images in our resubmission. We will also improve the color combination to improve visibility of colocalization of DLK1 with Insulin.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>The manuscript by Gitanjali Roy et al. applies deep transfer learning (DEGAS) to assign patient-level disease attributes (metadata) to single cells of T2D and non-diabetic patients, including obese patients. This led to the identification of a singular cluster of T2D-associated β-cells; and two subpopulations of obese- β-cells derived from either non-diabetic or T2D donors. The objective was to identify novel and established genes implicated in T2D and obesity. Their final goal is to validate their findings at the protein level using immunohistochemistry of pancreas tissue from non-diabetic and T2D organ donors.</p>
<p>Strengths:</p>
<p>This paper is well-written, and the findings are relevant for β-cell heterogeneity in T2D and obesity.</p>
</disp-quote>
<p>We thank the reviewer for their constructive critiques and positive feedback. We believe this study can improve our understanding β-cell heterogeneity in the context of T2D and obesity.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>The validation they provide is not sufficiently strong: no DLK1 immunohistochemistry is shown of obese patient-derived sections. Additional presumptive relevant candidates from this transcriptomic analysis should be screened for, at the protein level.</p>
</disp-quote>
<p>Thank the reviewer for this suggestion. We are planning to perform new immunostaining of DLK1 in human pancreas tissue sections from non-diabetic lean, non-diabetic obese, T2D lean, and T2D obese donors. We also note that Table S6 contains the patient metadata for the pancreas samples we show in the current manuscript. Two of the T2D donors have BMI &gt; 30 (obese). However, the non-diabetic donors have BMI between 26-29. Our new planned studies should address the question of differential DLK1 expression / beta cell heterogeneity in the context of both diabetes and obesity.</p>
</body>
</sub-article>
</article>